FALSE2020Q3000031015812/3100003101582020-01-012020-09-300000310158us-gaap:CommonStockMember2020-01-012020-09-300000310158mrk:A1.125Notesdue2021Member2020-01-012020-09-300000310158mrk:A0.500Notesdue2024Member2020-01-012020-09-300000310158mrk:A1.875Notesdue2026Member2020-01-012020-09-300000310158mrk:A2.500Notesdue2034Member2020-01-012020-09-300000310158mrk:A1.375Notesdue2036Member2020-01-012020-09-30xbrli:shares00003101582020-10-31iso4217:USD00003101582020-07-012020-09-3000003101582019-07-012019-09-3000003101582019-01-012019-09-30iso4217:USDxbrli:shares00003101582020-09-3000003101582019-12-3100003101582018-12-3100003101582019-09-300000310158srt:ScenarioForecastMembermrk:VelosBioMember2020-11-012020-11-300000310158mrk:SeagenMember2020-09-012020-09-300000310158mrk:SeagenMember2020-09-300000310158us-gaap:ForwardContractsMemberus-gaap:ResearchAndDevelopmentExpenseMember2020-07-012020-09-300000310158us-gaap:ForwardContractsMemberus-gaap:ResearchAndDevelopmentExpenseMemberus-gaap:SubsequentEventMember2020-10-012020-10-310000310158mrk:RegulatoryMilestonesMembermrk:SeagenMember2020-09-012020-09-300000310158mrk:SalesBasedMilestonesMembermrk:SeagenMember2020-09-012020-09-300000310158mrk:TukysaMembermrk:SeagenMember2020-09-012020-09-300000310158mrk:TukysaMembermrk:RegulatoryMilestonesMembermrk:SeagenMember2020-09-012020-09-30xbrli:pure0000310158srt:MinimumMembermrk:TukysaMembermrk:SeagenMember2020-09-012020-09-300000310158mrk:TukysaMembersrt:MaximumMembermrk:SeagenMember2020-09-012020-09-30iso4217:EUR0000310158mrk:DunboyneMember2020-09-012020-09-300000310158mrk:DunboyneMember2020-09-300000310158mrk:SentinelMember2020-07-012020-07-310000310158mrk:SentinelMemberus-gaap:DevelopedTechnologyRightsMember2020-07-012020-07-310000310158mrk:SentinelMemberus-gaap:DevelopedTechnologyRightsMember2020-07-310000310158us-gaap:DevelopedTechnologyRightsMembermrk:SentinelMember2020-07-012020-07-310000310158mrk:ThemisMember2020-06-012020-06-300000310158mrk:ThemisMember2020-06-300000310158mrk:DevelopmentMilestonesMembermrk:ThemisMember2020-06-300000310158mrk:ThemisMembermrk:RegulatoryMilestonesMember2020-06-300000310158mrk:ThemisMembermrk:SalesBasedMilestonesMember2020-06-300000310158mrk:IAVIMember2020-05-012020-05-310000310158mrk:ArQuleMember2020-01-162020-01-160000310158mrk:ArQuleMember2020-01-160000310158us-gaap:MeasurementInputDiscountRateMembermrk:ArQuleMember2020-01-160000310158mrk:PelotonMember2019-07-012019-07-310000310158mrk:PelotonMembermrk:RegulatoryMilestonesMember2019-07-310000310158mrk:PelotonMembermrk:CommercialMilestoneMember2019-07-310000310158mrk:PelotonMembermrk:SalesBasedMilestonesMember2019-07-310000310158mrk:PelotonMember2019-07-310000310158mrk:AntelliqMember2019-04-012019-04-010000310158mrk:AntelliqMember2019-04-010000310158srt:MinimumMembermrk:AntelliqMemberus-gaap:DevelopedTechnologyRightsMember2019-04-012019-04-010000310158mrk:AntelliqMembersrt:MaximumMemberus-gaap:DevelopedTechnologyRightsMember2019-04-012019-04-010000310158us-gaap:MeasurementInputDiscountRateMembermrk:AntelliqMember2019-04-010000310158mrk:ImmuneDesignMember2019-04-012019-04-300000310158mrk:ImmuneDesignMember2019-04-300000310158mrk:AstraZenecaMember2017-07-012017-07-310000310158mrk:LynparzaMembermrk:AstraZenecaMembermrk:SalesBasedMilestonesMember2020-04-012020-06-300000310158mrk:LynparzaMembermrk:AstraZenecaMembermrk:SalesBasedMilestonesMember2020-06-300000310158mrk:LynparzaMembermrk:AstraZenecaMembermrk:SalesBasedMilestonesMember2017-08-012019-12-310000310158mrk:LynparzaMembermrk:AstraZenecaMembermrk:SalesBasedMilestonesMember2019-01-012019-12-310000310158mrk:LynparzaMembermrk:AstraZenecaMembermrk:SalesBasedMilestonesMember2018-01-012018-12-310000310158mrk:LynparzaMembermrk:AstraZenecaMembermrk:SalesBasedMilestonesMember2020-01-012020-09-300000310158mrk:AstraZenecaMembermrk:SalesBasedMilestonesMember2020-01-012020-09-300000310158mrk:LynparzaMembermrk:AstraZenecaMembermrk:RegulatoryMilestonesMember2020-04-012020-06-300000310158mrk:LynparzaMembermrk:AstraZenecaMembermrk:RegulatoryMilestonesMember2019-01-012019-12-310000310158mrk:LynparzaMembermrk:AstraZenecaMembermrk:RegulatoryMilestonesMember2018-01-012018-12-310000310158mrk:LynparzaMembermrk:AstraZenecaMembermrk:RegulatoryMilestonesMember2020-01-012020-09-300000310158mrk:LynparzaMemberus-gaap:OtherNoncurrentAssetsMember2020-09-300000310158mrk:AstraZenecaMembermrk:AlliancerevenueLynparzaMemberus-gaap:CollaborativeArrangementMemberus-gaap:SalesMember2020-07-012020-09-300000310158mrk:AstraZenecaMembermrk:AlliancerevenueLynparzaMemberus-gaap:CollaborativeArrangementMemberus-gaap:SalesMember2019-07-012019-09-300000310158mrk:AstraZenecaMembermrk:AlliancerevenueLynparzaMemberus-gaap:CollaborativeArrangementMemberus-gaap:SalesMember2020-01-012020-09-300000310158mrk:AstraZenecaMembermrk:AlliancerevenueLynparzaMemberus-gaap:CollaborativeArrangementMemberus-gaap:SalesMember2019-01-012019-09-300000310158mrk:AstraZenecaMembermrk:AllianceRevenueKoselugoMemberus-gaap:CollaborativeArrangementMemberus-gaap:SalesMember2020-07-012020-09-300000310158mrk:AstraZenecaMembermrk:AllianceRevenueKoselugoMemberus-gaap:CollaborativeArrangementMemberus-gaap:SalesMember2019-07-012019-09-300000310158mrk:AstraZenecaMembermrk:AllianceRevenueKoselugoMemberus-gaap:CollaborativeArrangementMemberus-gaap:SalesMember2020-01-012020-09-300000310158mrk:AstraZenecaMembermrk:AllianceRevenueKoselugoMemberus-gaap:CollaborativeArrangementMemberus-gaap:SalesMember2019-01-012019-09-300000310158mrk:AstraZenecaMemberus-gaap:CollaborativeArrangementMemberus-gaap:SalesMember2020-07-012020-09-300000310158mrk:AstraZenecaMemberus-gaap:CollaborativeArrangementMemberus-gaap:SalesMember2019-07-012019-09-300000310158mrk:AstraZenecaMemberus-gaap:CollaborativeArrangementMemberus-gaap:SalesMember2020-01-012020-09-300000310158mrk:AstraZenecaMemberus-gaap:CollaborativeArrangementMemberus-gaap:SalesMember2019-01-012019-09-300000310158mrk:AstraZenecaMemberus-gaap:CostOfSalesMemberus-gaap:CollaborativeArrangementMember2020-07-012020-09-300000310158mrk:AstraZenecaMemberus-gaap:CostOfSalesMemberus-gaap:CollaborativeArrangementMember2019-07-012019-09-300000310158mrk:AstraZenecaMemberus-gaap:CostOfSalesMemberus-gaap:CollaborativeArrangementMember2020-01-012020-09-300000310158mrk:AstraZenecaMemberus-gaap:CostOfSalesMemberus-gaap:CollaborativeArrangementMember2019-01-012019-09-300000310158mrk:AstraZenecaMemberus-gaap:SellingGeneralAndAdministrativeExpensesMemberus-gaap:CollaborativeArrangementMember2020-07-012020-09-300000310158mrk:AstraZenecaMemberus-gaap:SellingGeneralAndAdministrativeExpensesMemberus-gaap:CollaborativeArrangementMember2019-07-012019-09-300000310158mrk:AstraZenecaMemberus-gaap:SellingGeneralAndAdministrativeExpensesMemberus-gaap:CollaborativeArrangementMember2020-01-012020-09-300000310158mrk:AstraZenecaMemberus-gaap:SellingGeneralAndAdministrativeExpensesMemberus-gaap:CollaborativeArrangementMember2019-01-012019-09-300000310158mrk:AstraZenecaMemberus-gaap:ResearchAndDevelopmentExpenseMemberus-gaap:CollaborativeArrangementMember2020-07-012020-09-300000310158mrk:AstraZenecaMemberus-gaap:ResearchAndDevelopmentExpenseMemberus-gaap:CollaborativeArrangementMember2019-07-012019-09-300000310158mrk:AstraZenecaMemberus-gaap:ResearchAndDevelopmentExpenseMemberus-gaap:CollaborativeArrangementMember2020-01-012020-09-300000310158mrk:AstraZenecaMemberus-gaap:ResearchAndDevelopmentExpenseMemberus-gaap:CollaborativeArrangementMember2019-01-012019-09-300000310158mrk:AstraZenecaMemberus-gaap:CollaborativeArrangementMemberus-gaap:OtherCurrentAssetsMember2020-09-300000310158mrk:AstraZenecaMemberus-gaap:CollaborativeArrangementMemberus-gaap:OtherCurrentAssetsMember2019-12-310000310158mrk:AstraZenecaMemberus-gaap:AccountsPayableAndAccruedLiabilitiesMemberus-gaap:CollaborativeArrangementMember2020-09-300000310158mrk:AstraZenecaMemberus-gaap:AccountsPayableAndAccruedLiabilitiesMemberus-gaap:CollaborativeArrangementMember2019-12-310000310158mrk:EisaiMember2018-03-012018-03-310000310158mrk:EisaiMembersrt:ScenarioForecastMember2018-03-012021-03-310000310158mrk:EisaiMember2019-03-012019-03-310000310158mrk:EisaiMember2020-03-012020-03-310000310158mrk:EisaiMembersrt:ScenarioForecastMember2021-03-012021-03-310000310158mrk:EisaiMembermrk:LenvimaMembermrk:SalesBasedMilestonesMember2020-04-012020-06-300000310158mrk:EisaiMembermrk:LenvimaMembermrk:SalesBasedMilestonesMember2020-06-300000310158mrk:EisaiMembermrk:LenvimaMembermrk:SalesBasedMilestonesMember2018-04-012019-12-310000310158mrk:EisaiMembermrk:LenvimaMembermrk:SalesBasedMilestonesMember2019-01-012019-12-310000310158mrk:EisaiMembermrk:LenvimaMembermrk:SalesBasedMilestonesMember2020-01-012020-09-300000310158mrk:EisaiMembermrk:SalesBasedMilestonesMember2020-01-012020-09-300000310158mrk:EisaiMembermrk:LenvimaMembermrk:RegulatoryMilestonesMember2018-01-012018-12-310000310158mrk:EisaiMembermrk:RegulatoryMilestonesMember2020-01-012020-09-300000310158us-gaap:OtherNoncurrentAssetsMembermrk:LenvimaMember2020-09-300000310158mrk:EisaiMemberus-gaap:CollaborativeArrangementMemberus-gaap:SalesMember2020-07-012020-09-300000310158mrk:EisaiMemberus-gaap:CollaborativeArrangementMemberus-gaap:SalesMember2019-07-012019-09-300000310158mrk:EisaiMemberus-gaap:CollaborativeArrangementMemberus-gaap:SalesMember2020-01-012020-09-300000310158mrk:EisaiMemberus-gaap:CollaborativeArrangementMemberus-gaap:SalesMember2019-01-012019-09-300000310158mrk:EisaiMemberus-gaap:CostOfSalesMemberus-gaap:CollaborativeArrangementMember2020-07-012020-09-300000310158mrk:EisaiMemberus-gaap:CostOfSalesMemberus-gaap:CollaborativeArrangementMember2019-07-012019-09-300000310158mrk:EisaiMemberus-gaap:CostOfSalesMemberus-gaap:CollaborativeArrangementMember2020-01-012020-09-300000310158mrk:EisaiMemberus-gaap:CostOfSalesMemberus-gaap:CollaborativeArrangementMember2019-01-012019-09-300000310158mrk:EisaiMemberus-gaap:SellingGeneralAndAdministrativeExpensesMemberus-gaap:CollaborativeArrangementMember2020-07-012020-09-300000310158mrk:EisaiMemberus-gaap:SellingGeneralAndAdministrativeExpensesMemberus-gaap:CollaborativeArrangementMember2019-07-012019-09-300000310158mrk:EisaiMemberus-gaap:SellingGeneralAndAdministrativeExpensesMemberus-gaap:CollaborativeArrangementMember2020-01-012020-09-300000310158mrk:EisaiMemberus-gaap:SellingGeneralAndAdministrativeExpensesMemberus-gaap:CollaborativeArrangementMember2019-01-012019-09-300000310158mrk:EisaiMemberus-gaap:ResearchAndDevelopmentExpenseMemberus-gaap:CollaborativeArrangementMember2020-07-012020-09-300000310158mrk:EisaiMemberus-gaap:ResearchAndDevelopmentExpenseMemberus-gaap:CollaborativeArrangementMember2019-07-012019-09-300000310158mrk:EisaiMemberus-gaap:ResearchAndDevelopmentExpenseMemberus-gaap:CollaborativeArrangementMember2020-01-012020-09-300000310158mrk:EisaiMemberus-gaap:ResearchAndDevelopmentExpenseMemberus-gaap:CollaborativeArrangementMember2019-01-012019-09-300000310158mrk:EisaiMemberus-gaap:CollaborativeArrangementMemberus-gaap:OtherCurrentAssetsMember2020-09-300000310158mrk:EisaiMemberus-gaap:CollaborativeArrangementMemberus-gaap:OtherCurrentAssetsMember2019-12-310000310158mrk:EisaiMemberus-gaap:AccountsPayableAndAccruedLiabilitiesMemberus-gaap:CollaborativeArrangementMember2020-09-300000310158mrk:EisaiMemberus-gaap:AccountsPayableAndAccruedLiabilitiesMemberus-gaap:CollaborativeArrangementMember2019-12-310000310158mrk:EisaiMemberus-gaap:OtherNoncurrentLiabilitiesMemberus-gaap:CollaborativeArrangementMember2020-09-300000310158mrk:EisaiMemberus-gaap:OtherNoncurrentLiabilitiesMemberus-gaap:CollaborativeArrangementMember2019-12-310000310158mrk:SalesBasedMilestonesMembermrk:BayerAGMember2019-01-012019-12-310000310158mrk:SalesBasedMilestonesMembermrk:BayerAGMember2018-01-012018-12-310000310158mrk:SalesBasedMilestonesMembermrk:BayerAGMember2020-01-012020-09-300000310158us-gaap:OtherIntangibleAssetsMembermrk:AdempasMember2020-09-300000310158us-gaap:CollaborativeArrangementMemberus-gaap:SalesMembermrk:BayerAGMember2020-07-012020-09-300000310158us-gaap:CollaborativeArrangementMemberus-gaap:SalesMembermrk:BayerAGMember2019-07-012019-09-300000310158us-gaap:CollaborativeArrangementMemberus-gaap:SalesMembermrk:BayerAGMember2020-01-012020-09-300000310158us-gaap:CollaborativeArrangementMemberus-gaap:SalesMembermrk:BayerAGMember2019-01-012019-09-300000310158us-gaap:CostOfSalesMemberus-gaap:CollaborativeArrangementMembermrk:BayerAGMember2020-07-012020-09-300000310158us-gaap:CostOfSalesMemberus-gaap:CollaborativeArrangementMembermrk:BayerAGMember2019-07-012019-09-300000310158us-gaap:CostOfSalesMemberus-gaap:CollaborativeArrangementMembermrk:BayerAGMember2020-01-012020-09-300000310158us-gaap:CostOfSalesMemberus-gaap:CollaborativeArrangementMembermrk:BayerAGMember2019-01-012019-09-300000310158us-gaap:SellingGeneralAndAdministrativeExpensesMemberus-gaap:CollaborativeArrangementMembermrk:BayerAGMember2020-07-012020-09-300000310158us-gaap:SellingGeneralAndAdministrativeExpensesMemberus-gaap:CollaborativeArrangementMembermrk:BayerAGMember2019-07-012019-09-300000310158us-gaap:SellingGeneralAndAdministrativeExpensesMemberus-gaap:CollaborativeArrangementMembermrk:BayerAGMember2020-01-012020-09-300000310158us-gaap:SellingGeneralAndAdministrativeExpensesMemberus-gaap:CollaborativeArrangementMembermrk:BayerAGMember2019-01-012019-09-300000310158us-gaap:ResearchAndDevelopmentExpenseMemberus-gaap:CollaborativeArrangementMembermrk:BayerAGMember2020-07-012020-09-300000310158us-gaap:ResearchAndDevelopmentExpenseMemberus-gaap:CollaborativeArrangementMembermrk:BayerAGMember2019-07-012019-09-300000310158us-gaap:ResearchAndDevelopmentExpenseMemberus-gaap:CollaborativeArrangementMembermrk:BayerAGMember2020-01-012020-09-300000310158us-gaap:ResearchAndDevelopmentExpenseMemberus-gaap:CollaborativeArrangementMembermrk:BayerAGMember2019-01-012019-09-300000310158us-gaap:CollaborativeArrangementMemberus-gaap:OtherCurrentAssetsMembermrk:BayerAGMember2020-09-300000310158us-gaap:CollaborativeArrangementMemberus-gaap:OtherCurrentAssetsMembermrk:BayerAGMember2019-12-310000310158us-gaap:OtherNoncurrentLiabilitiesMemberus-gaap:CollaborativeArrangementMembermrk:BayerAGMember2020-09-300000310158us-gaap:OtherNoncurrentLiabilitiesMemberus-gaap:CollaborativeArrangementMembermrk:BayerAGMember2019-12-310000310158srt:ScenarioForecastMember2020-12-310000310158us-gaap:CostOfSalesMemberus-gaap:OneTimeTerminationBenefitsMember2020-07-012020-09-300000310158us-gaap:CostOfSalesMembermrk:AcceleratedDepreciationMember2020-07-012020-09-300000310158us-gaap:OtherRestructuringMemberus-gaap:CostOfSalesMember2020-07-012020-09-300000310158us-gaap:CostOfSalesMember2020-07-012020-09-300000310158us-gaap:CostOfSalesMemberus-gaap:OneTimeTerminationBenefitsMember2020-01-012020-09-300000310158us-gaap:CostOfSalesMembermrk:AcceleratedDepreciationMember2020-01-012020-09-300000310158us-gaap:OtherRestructuringMemberus-gaap:CostOfSalesMember2020-01-012020-09-300000310158us-gaap:CostOfSalesMember2020-01-012020-09-300000310158us-gaap:SellingGeneralAndAdministrativeExpensesMemberus-gaap:OneTimeTerminationBenefitsMember2020-07-012020-09-300000310158us-gaap:SellingGeneralAndAdministrativeExpensesMembermrk:AcceleratedDepreciationMember2020-07-012020-09-300000310158us-gaap:OtherRestructuringMemberus-gaap:SellingGeneralAndAdministrativeExpensesMember2020-07-012020-09-300000310158us-gaap:SellingGeneralAndAdministrativeExpensesMember2020-07-012020-09-300000310158us-gaap:SellingGeneralAndAdministrativeExpensesMemberus-gaap:OneTimeTerminationBenefitsMember2020-01-012020-09-300000310158us-gaap:SellingGeneralAndAdministrativeExpensesMembermrk:AcceleratedDepreciationMember2020-01-012020-09-300000310158us-gaap:OtherRestructuringMemberus-gaap:SellingGeneralAndAdministrativeExpensesMember2020-01-012020-09-300000310158us-gaap:SellingGeneralAndAdministrativeExpensesMember2020-01-012020-09-300000310158us-gaap:ResearchAndDevelopmentExpenseMemberus-gaap:OneTimeTerminationBenefitsMember2020-07-012020-09-300000310158us-gaap:ResearchAndDevelopmentExpenseMembermrk:AcceleratedDepreciationMember2020-07-012020-09-300000310158us-gaap:OtherRestructuringMemberus-gaap:ResearchAndDevelopmentExpenseMember2020-07-012020-09-300000310158us-gaap:ResearchAndDevelopmentExpenseMember2020-07-012020-09-300000310158us-gaap:ResearchAndDevelopmentExpenseMemberus-gaap:OneTimeTerminationBenefitsMember2020-01-012020-09-300000310158us-gaap:ResearchAndDevelopmentExpenseMembermrk:AcceleratedDepreciationMember2020-01-012020-09-300000310158us-gaap:OtherRestructuringMemberus-gaap:ResearchAndDevelopmentExpenseMember2020-01-012020-09-300000310158us-gaap:ResearchAndDevelopmentExpenseMember2020-01-012020-09-300000310158us-gaap:OneTimeTerminationBenefitsMemberus-gaap:RestructuringChargesMember2020-07-012020-09-300000310158us-gaap:RestructuringChargesMembermrk:AcceleratedDepreciationMember2020-07-012020-09-300000310158us-gaap:OtherRestructuringMemberus-gaap:RestructuringChargesMember2020-07-012020-09-300000310158us-gaap:RestructuringChargesMember2020-07-012020-09-300000310158us-gaap:OneTimeTerminationBenefitsMemberus-gaap:RestructuringChargesMember2020-01-012020-09-300000310158us-gaap:RestructuringChargesMembermrk:AcceleratedDepreciationMember2020-01-012020-09-300000310158us-gaap:OtherRestructuringMemberus-gaap:RestructuringChargesMember2020-01-012020-09-300000310158us-gaap:RestructuringChargesMember2020-01-012020-09-300000310158us-gaap:OneTimeTerminationBenefitsMember2020-07-012020-09-300000310158mrk:AcceleratedDepreciationMember2020-07-012020-09-300000310158us-gaap:OtherRestructuringMember2020-07-012020-09-300000310158us-gaap:OneTimeTerminationBenefitsMember2020-01-012020-09-300000310158mrk:AcceleratedDepreciationMember2020-01-012020-09-300000310158us-gaap:OtherRestructuringMember2020-01-012020-09-300000310158us-gaap:CostOfSalesMemberus-gaap:OneTimeTerminationBenefitsMember2019-07-012019-09-300000310158us-gaap:CostOfSalesMembermrk:AcceleratedDepreciationMember2019-07-012019-09-300000310158us-gaap:OtherRestructuringMemberus-gaap:CostOfSalesMember2019-07-012019-09-300000310158us-gaap:CostOfSalesMember2019-07-012019-09-300000310158us-gaap:CostOfSalesMemberus-gaap:OneTimeTerminationBenefitsMember2019-01-012019-09-300000310158us-gaap:CostOfSalesMembermrk:AcceleratedDepreciationMember2019-01-012019-09-300000310158us-gaap:OtherRestructuringMemberus-gaap:CostOfSalesMember2019-01-012019-09-300000310158us-gaap:CostOfSalesMember2019-01-012019-09-300000310158us-gaap:SellingGeneralAndAdministrativeExpensesMemberus-gaap:OneTimeTerminationBenefitsMember2019-07-012019-09-300000310158us-gaap:SellingGeneralAndAdministrativeExpensesMembermrk:AcceleratedDepreciationMember2019-07-012019-09-300000310158us-gaap:OtherRestructuringMemberus-gaap:SellingGeneralAndAdministrativeExpensesMember2019-07-012019-09-300000310158us-gaap:SellingGeneralAndAdministrativeExpensesMember2019-07-012019-09-300000310158us-gaap:SellingGeneralAndAdministrativeExpensesMemberus-gaap:OneTimeTerminationBenefitsMember2019-01-012019-09-300000310158us-gaap:SellingGeneralAndAdministrativeExpensesMembermrk:AcceleratedDepreciationMember2019-01-012019-09-300000310158us-gaap:OtherRestructuringMemberus-gaap:SellingGeneralAndAdministrativeExpensesMember2019-01-012019-09-300000310158us-gaap:SellingGeneralAndAdministrativeExpensesMember2019-01-012019-09-300000310158us-gaap:ResearchAndDevelopmentExpenseMemberus-gaap:OneTimeTerminationBenefitsMember2019-07-012019-09-300000310158us-gaap:ResearchAndDevelopmentExpenseMembermrk:AcceleratedDepreciationMember2019-07-012019-09-300000310158us-gaap:OtherRestructuringMemberus-gaap:ResearchAndDevelopmentExpenseMember2019-07-012019-09-300000310158us-gaap:ResearchAndDevelopmentExpenseMember2019-07-012019-09-300000310158us-gaap:ResearchAndDevelopmentExpenseMemberus-gaap:OneTimeTerminationBenefitsMember2019-01-012019-09-300000310158us-gaap:ResearchAndDevelopmentExpenseMembermrk:AcceleratedDepreciationMember2019-01-012019-09-300000310158us-gaap:OtherRestructuringMemberus-gaap:ResearchAndDevelopmentExpenseMember2019-01-012019-09-300000310158us-gaap:ResearchAndDevelopmentExpenseMember2019-01-012019-09-300000310158us-gaap:OneTimeTerminationBenefitsMemberus-gaap:RestructuringChargesMember2019-07-012019-09-300000310158us-gaap:RestructuringChargesMembermrk:AcceleratedDepreciationMember2019-07-012019-09-300000310158us-gaap:OtherRestructuringMemberus-gaap:RestructuringChargesMember2019-07-012019-09-300000310158us-gaap:RestructuringChargesMember2019-07-012019-09-300000310158us-gaap:OneTimeTerminationBenefitsMemberus-gaap:RestructuringChargesMember2019-01-012019-09-300000310158us-gaap:RestructuringChargesMembermrk:AcceleratedDepreciationMember2019-01-012019-09-300000310158us-gaap:OtherRestructuringMemberus-gaap:RestructuringChargesMember2019-01-012019-09-300000310158us-gaap:RestructuringChargesMember2019-01-012019-09-300000310158us-gaap:OneTimeTerminationBenefitsMember2019-07-012019-09-300000310158mrk:AcceleratedDepreciationMember2019-07-012019-09-300000310158us-gaap:OtherRestructuringMember2019-07-012019-09-300000310158us-gaap:OneTimeTerminationBenefitsMember2019-01-012019-09-300000310158mrk:AcceleratedDepreciationMember2019-01-012019-09-300000310158us-gaap:OtherRestructuringMember2019-01-012019-09-300000310158us-gaap:OneTimeTerminationBenefitsMember2019-12-310000310158mrk:AcceleratedDepreciationMember2019-12-310000310158us-gaap:OtherRestructuringMember2019-12-310000310158us-gaap:OneTimeTerminationBenefitsMember2020-09-300000310158mrk:AcceleratedDepreciationMember2020-09-300000310158us-gaap:OtherRestructuringMember2020-09-300000310158srt:MaximumMemberus-gaap:DesignatedAsHedgingInstrumentMember2020-01-012020-09-300000310158us-gaap:NondesignatedMembersrt:MaximumMember2020-01-012020-09-300000310158us-gaap:ForeignExchangeContractMember2020-07-012020-09-300000310158us-gaap:ForeignExchangeContractMember2019-07-012019-09-300000310158us-gaap:ForeignExchangeContractMember2020-01-012020-09-300000310158us-gaap:ForeignExchangeContractMember2019-01-012019-09-300000310158us-gaap:OtherNonoperatingIncomeExpenseMemberus-gaap:ForeignExchangeContractMember2020-07-012020-09-300000310158us-gaap:OtherNonoperatingIncomeExpenseMemberus-gaap:ForeignExchangeContractMember2019-07-012019-09-300000310158us-gaap:OtherNonoperatingIncomeExpenseMemberus-gaap:ForeignExchangeContractMember2020-01-012020-09-300000310158us-gaap:OtherNonoperatingIncomeExpenseMemberus-gaap:ForeignExchangeContractMember2019-01-012019-09-300000310158mrk:EurodominatedNotesMember2020-07-012020-09-300000310158mrk:EurodominatedNotesMember2019-07-012019-09-300000310158mrk:EurodominatedNotesMember2020-01-012020-09-300000310158mrk:EurodominatedNotesMember2019-01-012019-09-300000310158mrk:EurodominatedNotesMemberus-gaap:OtherNonoperatingIncomeExpenseMember2020-07-012020-09-300000310158mrk:EurodominatedNotesMemberus-gaap:OtherNonoperatingIncomeExpenseMember2019-07-012019-09-300000310158mrk:EurodominatedNotesMemberus-gaap:OtherNonoperatingIncomeExpenseMember2020-01-012020-09-300000310158mrk:EurodominatedNotesMemberus-gaap:OtherNonoperatingIncomeExpenseMember2019-01-012019-09-30mrk:interest_rate_swap0000310158us-gaap:InterestRateSwapMember2020-02-290000310158mrk:A1.85NotesDue2020Member2020-02-290000310158us-gaap:InterestRateSwapMember2020-09-300000310158mrk:A3.875NotesDue2021Memberus-gaap:InterestRateSwapMember2020-09-300000310158us-gaap:InterestRateSwapMembermrk:A2.40NotesDue2022Member2020-09-300000310158us-gaap:InterestRateSwapMembermrk:A2.35NotesDue2022Member2020-09-300000310158mrk:LongTermDebtCurrentMaturitiesMember2020-09-300000310158mrk:LongTermDebtCurrentMaturitiesMember2019-12-310000310158mrk:LongTermDebtExcludingCurrentMaturitiesMember2020-09-300000310158mrk:LongTermDebtExcludingCurrentMaturitiesMember2019-12-310000310158us-gaap:InterestRateContractMemberus-gaap:OtherCurrentAssetsMemberus-gaap:DesignatedAsHedgingInstrumentMember2020-09-300000310158us-gaap:InterestRateContractMemberus-gaap:OtherCurrentAssetsMemberus-gaap:DesignatedAsHedgingInstrumentMember2019-12-310000310158us-gaap:OtherAssetsMemberus-gaap:InterestRateContractMemberus-gaap:DesignatedAsHedgingInstrumentMember2020-09-300000310158us-gaap:OtherAssetsMemberus-gaap:InterestRateContractMemberus-gaap:DesignatedAsHedgingInstrumentMember2019-12-310000310158us-gaap:InterestRateContractMemberus-gaap:AccruedLiabilitiesMemberus-gaap:DesignatedAsHedgingInstrumentMember2020-09-300000310158us-gaap:InterestRateContractMemberus-gaap:AccruedLiabilitiesMemberus-gaap:DesignatedAsHedgingInstrumentMember2019-12-310000310158us-gaap:ForeignExchangeContractMemberus-gaap:OtherCurrentAssetsMemberus-gaap:DesignatedAsHedgingInstrumentMember2020-09-300000310158us-gaap:ForeignExchangeContractMemberus-gaap:OtherCurrentAssetsMemberus-gaap:DesignatedAsHedgingInstrumentMember2019-12-310000310158us-gaap:OtherAssetsMemberus-gaap:ForeignExchangeContractMemberus-gaap:DesignatedAsHedgingInstrumentMember2020-09-300000310158us-gaap:OtherAssetsMemberus-gaap:ForeignExchangeContractMemberus-gaap:DesignatedAsHedgingInstrumentMember2019-12-310000310158us-gaap:ForeignExchangeContractMemberus-gaap:AccruedLiabilitiesMemberus-gaap:DesignatedAsHedgingInstrumentMember2020-09-300000310158us-gaap:ForeignExchangeContractMemberus-gaap:AccruedLiabilitiesMemberus-gaap:DesignatedAsHedgingInstrumentMember2019-12-310000310158us-gaap:ForeignExchangeContractMemberus-gaap:OtherNoncurrentLiabilitiesMemberus-gaap:DesignatedAsHedgingInstrumentMember2020-09-300000310158us-gaap:ForeignExchangeContractMemberus-gaap:OtherNoncurrentLiabilitiesMemberus-gaap:DesignatedAsHedgingInstrumentMember2019-12-310000310158us-gaap:DesignatedAsHedgingInstrumentMember2020-09-300000310158us-gaap:DesignatedAsHedgingInstrumentMember2019-12-310000310158us-gaap:NondesignatedMemberus-gaap:ForeignExchangeContractMemberus-gaap:OtherCurrentAssetsMember2020-09-300000310158us-gaap:NondesignatedMemberus-gaap:ForeignExchangeContractMemberus-gaap:OtherCurrentAssetsMember2019-12-310000310158us-gaap:NondesignatedMemberus-gaap:ForeignExchangeContractMemberus-gaap:AccruedLiabilitiesMember2020-09-300000310158us-gaap:NondesignatedMemberus-gaap:ForeignExchangeContractMemberus-gaap:AccruedLiabilitiesMember2019-12-310000310158us-gaap:ForwardContractsMemberus-gaap:NondesignatedMemberus-gaap:AccruedLiabilitiesMember2020-09-300000310158us-gaap:ForwardContractsMemberus-gaap:NondesignatedMemberus-gaap:AccruedLiabilitiesMember2019-12-310000310158us-gaap:NondesignatedMember2020-09-300000310158us-gaap:NondesignatedMember2019-12-310000310158us-gaap:OtherNonoperatingIncomeExpenseMemberus-gaap:InterestRateSwapMember2020-07-012020-09-300000310158us-gaap:OtherNonoperatingIncomeExpenseMemberus-gaap:InterestRateSwapMember2019-07-012019-09-300000310158us-gaap:OtherNonoperatingIncomeExpenseMemberus-gaap:InterestRateSwapMember2020-01-012020-09-300000310158us-gaap:OtherNonoperatingIncomeExpenseMemberus-gaap:InterestRateSwapMember2019-01-012019-09-300000310158us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMemberus-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMemberus-gaap:ForeignExchangeContractMember2020-07-012020-09-300000310158us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMemberus-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMemberus-gaap:ForeignExchangeContractMember2019-07-012019-09-300000310158us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMemberus-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMemberus-gaap:ForeignExchangeContractMember2020-01-012020-09-300000310158us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMemberus-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMemberus-gaap:ForeignExchangeContractMember2019-01-012019-09-300000310158us-gaap:InterestRateSwapMember2020-07-012020-09-300000310158us-gaap:InterestRateSwapMember2019-07-012019-09-300000310158us-gaap:InterestRateSwapMember2020-01-012020-09-300000310158us-gaap:InterestRateSwapMember2019-01-012019-09-300000310158us-gaap:OtherNonoperatingIncomeExpenseMemberus-gaap:CurrencySwapMember2020-07-012020-09-300000310158us-gaap:OtherNonoperatingIncomeExpenseMemberus-gaap:CurrencySwapMember2019-07-012019-09-300000310158us-gaap:OtherNonoperatingIncomeExpenseMemberus-gaap:CurrencySwapMember2020-01-012020-09-300000310158us-gaap:OtherNonoperatingIncomeExpenseMemberus-gaap:CurrencySwapMember2019-01-012019-09-300000310158us-gaap:ForeignExchangeFutureMemberus-gaap:SalesMember2020-07-012020-09-300000310158us-gaap:ForeignExchangeFutureMemberus-gaap:SalesMember2019-07-012019-09-300000310158us-gaap:ForeignExchangeFutureMemberus-gaap:SalesMember2020-01-012020-09-300000310158us-gaap:ForeignExchangeFutureMemberus-gaap:SalesMember2019-01-012019-09-300000310158us-gaap:OtherNonoperatingIncomeExpenseMemberus-gaap:TreasuryLockMember2020-07-012020-09-300000310158us-gaap:OtherNonoperatingIncomeExpenseMemberus-gaap:TreasuryLockMember2019-07-012019-09-300000310158us-gaap:OtherNonoperatingIncomeExpenseMemberus-gaap:TreasuryLockMember2020-01-012020-09-300000310158us-gaap:OtherNonoperatingIncomeExpenseMemberus-gaap:TreasuryLockMember2019-01-012019-09-300000310158us-gaap:ForwardContractsMemberus-gaap:ResearchAndDevelopmentExpenseMember2019-07-012019-09-300000310158us-gaap:ForwardContractsMemberus-gaap:ResearchAndDevelopmentExpenseMember2020-01-012020-09-300000310158us-gaap:ForwardContractsMemberus-gaap:ResearchAndDevelopmentExpenseMember2019-01-012019-09-300000310158us-gaap:USGovernmentAgenciesDebtSecuritiesMember2020-09-300000310158us-gaap:USGovernmentAgenciesDebtSecuritiesMember2019-12-310000310158us-gaap:ForeignGovernmentDebtSecuritiesMember2020-09-300000310158us-gaap:ForeignGovernmentDebtSecuritiesMember2019-12-310000310158us-gaap:CommercialPaperMember2020-09-300000310158us-gaap:CommercialPaperMember2019-12-310000310158us-gaap:CorporateDebtSecuritiesMember2020-09-300000310158us-gaap:CorporateDebtSecuritiesMember2019-12-310000310158us-gaap:AssetBackedSecuritiesMember2020-09-300000310158us-gaap:AssetBackedSecuritiesMember2019-12-310000310158us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Memberus-gaap:ForeignGovernmentDebtSecuritiesMember2020-09-300000310158us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Memberus-gaap:ForeignGovernmentDebtSecuritiesMember2020-09-300000310158us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Memberus-gaap:ForeignGovernmentDebtSecuritiesMember2020-09-300000310158us-gaap:FairValueMeasurementsRecurringMemberus-gaap:ForeignGovernmentDebtSecuritiesMember2020-09-300000310158us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Memberus-gaap:ForeignGovernmentDebtSecuritiesMember2019-12-310000310158us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Memberus-gaap:ForeignGovernmentDebtSecuritiesMember2019-12-310000310158us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Memberus-gaap:ForeignGovernmentDebtSecuritiesMember2019-12-310000310158us-gaap:FairValueMeasurementsRecurringMemberus-gaap:ForeignGovernmentDebtSecuritiesMember2019-12-310000310158us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Memberus-gaap:CommercialPaperMember2020-09-300000310158us-gaap:FairValueMeasurementsRecurringMemberus-gaap:CommercialPaperMemberus-gaap:FairValueInputsLevel2Member2020-09-300000310158us-gaap:FairValueMeasurementsRecurringMemberus-gaap:CommercialPaperMemberus-gaap:FairValueInputsLevel3Member2020-09-300000310158us-gaap:FairValueMeasurementsRecurringMemberus-gaap:CommercialPaperMember2020-09-300000310158us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Memberus-gaap:CommercialPaperMember2019-12-310000310158us-gaap:FairValueMeasurementsRecurringMemberus-gaap:CommercialPaperMemberus-gaap:FairValueInputsLevel2Member2019-12-310000310158us-gaap:FairValueMeasurementsRecurringMemberus-gaap:CommercialPaperMemberus-gaap:FairValueInputsLevel3Member2019-12-310000310158us-gaap:FairValueMeasurementsRecurringMemberus-gaap:CommercialPaperMember2019-12-310000310158us-gaap:CorporateDebtSecuritiesMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Member2020-09-300000310158us-gaap:CorporateDebtSecuritiesMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Member2020-09-300000310158us-gaap:CorporateDebtSecuritiesMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2020-09-300000310158us-gaap:CorporateDebtSecuritiesMemberus-gaap:FairValueMeasurementsRecurringMember2020-09-300000310158us-gaap:CorporateDebtSecuritiesMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Member2019-12-310000310158us-gaap:CorporateDebtSecuritiesMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Member2019-12-310000310158us-gaap:CorporateDebtSecuritiesMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2019-12-310000310158us-gaap:CorporateDebtSecuritiesMemberus-gaap:FairValueMeasurementsRecurringMember2019-12-310000310158us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Memberus-gaap:AssetBackedSecuritiesMember2020-09-300000310158us-gaap:FairValueMeasurementsRecurringMemberus-gaap:AssetBackedSecuritiesMemberus-gaap:FairValueInputsLevel2Member2020-09-300000310158us-gaap:FairValueMeasurementsRecurringMemberus-gaap:AssetBackedSecuritiesMemberus-gaap:FairValueInputsLevel3Member2020-09-300000310158us-gaap:FairValueMeasurementsRecurringMemberus-gaap:AssetBackedSecuritiesMember2020-09-300000310158us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Memberus-gaap:AssetBackedSecuritiesMember2019-12-310000310158us-gaap:FairValueMeasurementsRecurringMemberus-gaap:AssetBackedSecuritiesMemberus-gaap:FairValueInputsLevel2Member2019-12-310000310158us-gaap:FairValueMeasurementsRecurringMemberus-gaap:AssetBackedSecuritiesMemberus-gaap:FairValueInputsLevel3Member2019-12-310000310158us-gaap:FairValueMeasurementsRecurringMemberus-gaap:AssetBackedSecuritiesMember2019-12-310000310158us-gaap:USGovernmentAgenciesDebtSecuritiesMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Member2020-09-300000310158us-gaap:USGovernmentAgenciesDebtSecuritiesMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Member2020-09-300000310158us-gaap:USGovernmentAgenciesDebtSecuritiesMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2020-09-300000310158us-gaap:USGovernmentAgenciesDebtSecuritiesMemberus-gaap:FairValueMeasurementsRecurringMember2020-09-300000310158us-gaap:USGovernmentAgenciesDebtSecuritiesMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Member2019-12-310000310158us-gaap:USGovernmentAgenciesDebtSecuritiesMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Member2019-12-310000310158us-gaap:USGovernmentAgenciesDebtSecuritiesMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2019-12-310000310158us-gaap:USGovernmentAgenciesDebtSecuritiesMemberus-gaap:FairValueMeasurementsRecurringMember2019-12-310000310158us-gaap:EquitySecuritiesMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Member2020-09-300000310158us-gaap:EquitySecuritiesMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Member2020-09-300000310158us-gaap:EquitySecuritiesMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2020-09-300000310158us-gaap:EquitySecuritiesMemberus-gaap:FairValueMeasurementsRecurringMember2020-09-300000310158us-gaap:EquitySecuritiesMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Member2019-12-310000310158us-gaap:EquitySecuritiesMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Member2019-12-310000310158us-gaap:EquitySecuritiesMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2019-12-310000310158us-gaap:EquitySecuritiesMemberus-gaap:FairValueMeasurementsRecurringMember2019-12-310000310158us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Member2020-09-300000310158us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Member2020-09-300000310158us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2020-09-300000310158us-gaap:FairValueMeasurementsRecurringMember2020-09-300000310158us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Member2019-12-310000310158us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Member2019-12-310000310158us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2019-12-310000310158us-gaap:FairValueMeasurementsRecurringMember2019-12-310000310158us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Memberus-gaap:ForeignExchangeContractMember2020-09-300000310158us-gaap:FairValueMeasurementsRecurringMemberus-gaap:ForeignExchangeContractMemberus-gaap:FairValueInputsLevel2Member2020-09-300000310158us-gaap:FairValueMeasurementsRecurringMemberus-gaap:ForeignExchangeContractMemberus-gaap:FairValueInputsLevel3Member2020-09-300000310158us-gaap:FairValueMeasurementsRecurringMemberus-gaap:ForeignExchangeContractMember2020-09-300000310158us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Memberus-gaap:ForeignExchangeContractMember2019-12-310000310158us-gaap:FairValueMeasurementsRecurringMemberus-gaap:ForeignExchangeContractMemberus-gaap:FairValueInputsLevel2Member2019-12-310000310158us-gaap:FairValueMeasurementsRecurringMemberus-gaap:ForeignExchangeContractMemberus-gaap:FairValueInputsLevel3Member2019-12-310000310158us-gaap:FairValueMeasurementsRecurringMemberus-gaap:ForeignExchangeContractMember2019-12-310000310158us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Memberus-gaap:InterestRateSwapMember2020-09-300000310158us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Memberus-gaap:InterestRateSwapMember2020-09-300000310158us-gaap:FairValueMeasurementsRecurringMemberus-gaap:InterestRateSwapMemberus-gaap:FairValueInputsLevel3Member2020-09-300000310158us-gaap:FairValueMeasurementsRecurringMemberus-gaap:InterestRateSwapMember2020-09-300000310158us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Memberus-gaap:InterestRateSwapMember2019-12-310000310158us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Memberus-gaap:InterestRateSwapMember2019-12-310000310158us-gaap:FairValueMeasurementsRecurringMemberus-gaap:InterestRateSwapMemberus-gaap:FairValueInputsLevel3Member2019-12-310000310158us-gaap:FairValueMeasurementsRecurringMemberus-gaap:InterestRateSwapMember2019-12-310000310158us-gaap:ForeignExchangeOptionMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Member2020-09-300000310158us-gaap:ForeignExchangeOptionMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Member2020-09-300000310158us-gaap:ForeignExchangeOptionMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2020-09-300000310158us-gaap:ForeignExchangeOptionMemberus-gaap:FairValueMeasurementsRecurringMember2020-09-300000310158us-gaap:ForeignExchangeOptionMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Member2019-12-310000310158us-gaap:ForeignExchangeOptionMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Member2019-12-310000310158us-gaap:ForeignExchangeOptionMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2019-12-310000310158us-gaap:ForeignExchangeOptionMemberus-gaap:FairValueMeasurementsRecurringMember2019-12-310000310158us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Memberus-gaap:ForwardContractsMember2020-09-300000310158us-gaap:FairValueMeasurementsRecurringMemberus-gaap:ForwardContractsMemberus-gaap:FairValueInputsLevel2Member2020-09-300000310158us-gaap:FairValueMeasurementsRecurringMemberus-gaap:ForwardContractsMemberus-gaap:FairValueInputsLevel3Member2020-09-300000310158us-gaap:FairValueMeasurementsRecurringMemberus-gaap:ForwardContractsMember2020-09-300000310158us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Memberus-gaap:ForwardContractsMember2019-12-310000310158us-gaap:FairValueMeasurementsRecurringMemberus-gaap:ForwardContractsMemberus-gaap:FairValueInputsLevel2Member2019-12-310000310158us-gaap:FairValueMeasurementsRecurringMemberus-gaap:ForwardContractsMemberus-gaap:FairValueInputsLevel3Member2019-12-310000310158us-gaap:FairValueMeasurementsRecurringMemberus-gaap:ForwardContractsMember2019-12-310000310158us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Memberus-gaap:InterestRateContractMember2020-09-300000310158us-gaap:FairValueMeasurementsRecurringMemberus-gaap:InterestRateContractMemberus-gaap:FairValueInputsLevel2Member2020-09-300000310158us-gaap:FairValueMeasurementsRecurringMemberus-gaap:InterestRateContractMemberus-gaap:FairValueInputsLevel3Member2020-09-300000310158us-gaap:FairValueMeasurementsRecurringMemberus-gaap:InterestRateContractMember2020-09-300000310158us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Memberus-gaap:InterestRateContractMember2019-12-310000310158us-gaap:FairValueMeasurementsRecurringMemberus-gaap:InterestRateContractMemberus-gaap:FairValueInputsLevel2Member2019-12-310000310158us-gaap:FairValueMeasurementsRecurringMemberus-gaap:InterestRateContractMemberus-gaap:FairValueInputsLevel3Member2019-12-310000310158us-gaap:FairValueMeasurementsRecurringMemberus-gaap:InterestRateContractMember2019-12-310000310158us-gaap:AssetBackedSecuritiesMember2020-01-012020-09-300000310158us-gaap:FairValueInputsLevel2Member2020-09-300000310158us-gaap:FairValueInputsLevel2Member2019-12-310000310158mrk:SanofiPasteurMember2020-09-300000310158mrk:SanofiPasteurMember2019-12-310000310158mrk:SanofiPasteurMemberus-gaap:MeasurementInputDiscountRateMember2020-09-3000003101582019-10-012019-12-310000310158mrk:InventoryNotExpectedtobeSoldWithinOneYearMember2020-09-300000310158mrk:InventoryNotExpectedtobeSoldWithinOneYearMember2019-12-310000310158mrk:InventoriesProducedinPreparationforProductLaunchesMember2020-09-300000310158mrk:InventoriesProducedinPreparationforProductLaunchesMember2019-12-310000310158mrk:SivextroMember2019-07-012019-09-3000003101582020-06-300000310158mrk:A0.75notesdue2026Member2020-06-300000310158mrk:A1.45notesdue2030Member2020-06-300000310158mrk:A2.35notesdue2040Member2020-06-300000310158mrk:A2.45notesdue2050Member2020-06-30mrk:Case0000310158mrk:FosamaxMember2020-09-300000310158mrk:FosamaxMembermrk:FederalMembermrk:FemurFractureLitigationMember2014-03-012014-03-310000310158mrk:FosamaxMembermrk:FederalMembermrk:FemurFractureLitigationMember2020-09-300000310158mrk:FosamaxMembermrk:FemurFractureLitigationMembermrk:NewJerseyStateCourtMember2020-09-300000310158mrk:FosamaxMembermrk:CaliforniaStateCourtMembermrk:FemurFractureLitigationMember2020-09-300000310158mrk:FosamaxMembermrk:OtherStateCourtMembermrk:FemurFractureLitigationMember2020-09-30mrk:Claim0000310158mrk:JanuviaMember2020-09-300000310158mrk:JanuviaMembermrk:OtherStateCourtMember2020-09-300000310158mrk:JanuviaMembermrk:CasesCompanyAgreedToTollStatuteOfLimitationsMember2020-09-300000310158mrk:ZetiaantitrustlitigationMember2020-09-300000310158us-gaap:PatentsMember2020-01-012020-09-300000310158us-gaap:PatentsMember2020-09-300000310158mrk:LegalDefenseCostsMember2020-09-300000310158mrk:LegalDefenseCostsMember2019-12-310000310158us-gaap:CommonStockMember2019-06-300000310158us-gaap:AdditionalPaidInCapitalMember2019-06-300000310158us-gaap:RetainedEarningsMember2019-06-300000310158us-gaap:AccumulatedOtherComprehensiveIncomeMember2019-06-300000310158us-gaap:TreasuryStockMember2019-06-300000310158us-gaap:NoncontrollingInterestMember2019-06-3000003101582019-06-300000310158us-gaap:RetainedEarningsMember2019-07-012019-09-300000310158us-gaap:AccumulatedOtherComprehensiveIncomeMember2019-07-012019-09-300000310158us-gaap:TreasuryStockMember2019-07-012019-09-300000310158us-gaap:AdditionalPaidInCapitalMember2019-07-012019-09-300000310158us-gaap:NoncontrollingInterestMember2019-07-012019-09-300000310158us-gaap:CommonStockMember2019-09-300000310158us-gaap:AdditionalPaidInCapitalMember2019-09-300000310158us-gaap:RetainedEarningsMember2019-09-300000310158us-gaap:AccumulatedOtherComprehensiveIncomeMember2019-09-300000310158us-gaap:TreasuryStockMember2019-09-300000310158us-gaap:NoncontrollingInterestMember2019-09-300000310158us-gaap:CommonStockMember2020-06-300000310158us-gaap:AdditionalPaidInCapitalMember2020-06-300000310158us-gaap:RetainedEarningsMember2020-06-300000310158us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-06-300000310158us-gaap:TreasuryStockMember2020-06-300000310158us-gaap:NoncontrollingInterestMember2020-06-300000310158us-gaap:RetainedEarningsMember2020-07-012020-09-300000310158us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-07-012020-09-300000310158us-gaap:AdditionalPaidInCapitalMember2020-07-012020-09-300000310158us-gaap:TreasuryStockMember2020-07-012020-09-300000310158us-gaap:NoncontrollingInterestMember2020-07-012020-09-300000310158us-gaap:CommonStockMember2020-09-300000310158us-gaap:AdditionalPaidInCapitalMember2020-09-300000310158us-gaap:RetainedEarningsMember2020-09-300000310158us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-09-300000310158us-gaap:TreasuryStockMember2020-09-300000310158us-gaap:NoncontrollingInterestMember2020-09-300000310158us-gaap:CommonStockMember2018-12-310000310158us-gaap:AdditionalPaidInCapitalMember2018-12-310000310158us-gaap:RetainedEarningsMember2018-12-310000310158us-gaap:AccumulatedOtherComprehensiveIncomeMember2018-12-310000310158us-gaap:TreasuryStockMember2018-12-310000310158us-gaap:NoncontrollingInterestMember2018-12-310000310158us-gaap:RetainedEarningsMember2019-01-012019-09-300000310158us-gaap:AccumulatedOtherComprehensiveIncomeMember2019-01-012019-09-300000310158us-gaap:AdditionalPaidInCapitalMember2019-01-012019-09-300000310158us-gaap:TreasuryStockMember2019-01-012019-09-300000310158us-gaap:NoncontrollingInterestMember2019-01-012019-09-300000310158us-gaap:CommonStockMember2019-12-310000310158us-gaap:AdditionalPaidInCapitalMember2019-12-310000310158us-gaap:RetainedEarningsMember2019-12-310000310158us-gaap:AccumulatedOtherComprehensiveIncomeMember2019-12-310000310158us-gaap:TreasuryStockMember2019-12-310000310158us-gaap:NoncontrollingInterestMember2019-12-310000310158us-gaap:RetainedEarningsMember2020-01-012020-09-300000310158us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-01-012020-09-300000310158us-gaap:TreasuryStockMember2020-01-012020-09-300000310158us-gaap:AdditionalPaidInCapitalMember2020-01-012020-09-300000310158us-gaap:NoncontrollingInterestMember2020-01-012020-09-300000310158us-gaap:RestrictedStockUnitsRSUMember2020-01-012020-09-300000310158us-gaap:RestrictedStockUnitsRSUMember2019-01-012019-09-300000310158us-gaap:PerformanceSharesMember2020-01-012020-09-300000310158us-gaap:PerformanceSharesMember2019-01-012019-09-300000310158us-gaap:PensionPlansDefinedBenefitMember2020-01-012020-09-300000310158country:USus-gaap:PensionPlansDefinedBenefitMember2020-07-012020-09-300000310158us-gaap:ForeignPlanMemberus-gaap:PensionPlansDefinedBenefitMember2020-07-012020-09-300000310158country:USus-gaap:PensionPlansDefinedBenefitMember2019-07-012019-09-300000310158us-gaap:ForeignPlanMemberus-gaap:PensionPlansDefinedBenefitMember2019-07-012019-09-300000310158country:USus-gaap:PensionPlansDefinedBenefitMember2020-01-012020-09-300000310158us-gaap:ForeignPlanMemberus-gaap:PensionPlansDefinedBenefitMember2020-01-012020-09-300000310158country:USus-gaap:PensionPlansDefinedBenefitMember2019-01-012019-09-300000310158us-gaap:ForeignPlanMemberus-gaap:PensionPlansDefinedBenefitMember2019-01-012019-09-300000310158country:US2020-09-300000310158us-gaap:ForeignPlanMember2020-09-300000310158country:US2020-01-012020-09-300000310158us-gaap:ForeignPlanMember2020-01-012020-09-300000310158us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2020-01-012020-09-300000310158us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2020-07-012020-09-300000310158us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2019-07-012019-09-300000310158us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2019-01-012019-09-300000310158mrk:HealthcareServicesSegmentMember2019-01-012019-09-300000310158us-gaap:DomesticCountryMemberus-gaap:InternalRevenueServiceIRSMember2019-01-012019-09-300000310158us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2019-06-300000310158us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2019-06-300000310158us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2019-06-300000310158us-gaap:AccumulatedTranslationAdjustmentMember2019-06-300000310158us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2019-07-012019-09-300000310158us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2019-07-012019-09-300000310158us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2019-07-012019-09-300000310158us-gaap:AccumulatedTranslationAdjustmentMember2019-07-012019-09-300000310158us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2019-09-300000310158us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2019-09-300000310158us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2019-09-300000310158us-gaap:AccumulatedTranslationAdjustmentMember2019-09-300000310158us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2020-06-300000310158us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2020-06-300000310158us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2020-06-300000310158us-gaap:AccumulatedTranslationAdjustmentMember2020-06-300000310158us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2020-07-012020-09-300000310158us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2020-07-012020-09-300000310158us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2020-07-012020-09-300000310158us-gaap:AccumulatedTranslationAdjustmentMember2020-07-012020-09-300000310158us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2020-09-300000310158us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2020-09-300000310158us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2020-09-300000310158us-gaap:AccumulatedTranslationAdjustmentMember2020-09-300000310158us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2018-12-310000310158us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2018-12-310000310158us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2018-12-310000310158us-gaap:AccumulatedTranslationAdjustmentMember2018-12-310000310158us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2019-01-012019-09-300000310158us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2019-01-012019-09-300000310158us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2019-01-012019-09-300000310158us-gaap:AccumulatedTranslationAdjustmentMember2019-01-012019-09-300000310158us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2019-12-310000310158us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2019-12-310000310158us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2019-12-310000310158us-gaap:AccumulatedTranslationAdjustmentMember2019-12-310000310158us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2020-01-012020-09-300000310158us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2020-01-012020-09-300000310158us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2020-01-012020-09-300000310158us-gaap:AccumulatedTranslationAdjustmentMember2020-01-012020-09-30mrk:segment0000310158us-gaap:OperatingSegmentsMembercountry:USmrk:PharmaceuticalsegmentMembermrk:KeytrudaMember2020-07-012020-09-300000310158us-gaap:OperatingSegmentsMembermrk:PharmaceuticalsegmentMembermrk:InternationalMembermrk:KeytrudaMember2020-07-012020-09-300000310158us-gaap:OperatingSegmentsMembermrk:PharmaceuticalsegmentMembermrk:KeytrudaMember2020-07-012020-09-300000310158us-gaap:OperatingSegmentsMembercountry:USmrk:PharmaceuticalsegmentMembermrk:KeytrudaMember2019-07-012019-09-300000310158us-gaap:OperatingSegmentsMembermrk:PharmaceuticalsegmentMembermrk:InternationalMembermrk:KeytrudaMember2019-07-012019-09-300000310158us-gaap:OperatingSegmentsMembermrk:PharmaceuticalsegmentMembermrk:KeytrudaMember2019-07-012019-09-300000310158us-gaap:OperatingSegmentsMembercountry:USmrk:PharmaceuticalsegmentMembermrk:KeytrudaMember2020-01-012020-09-300000310158us-gaap:OperatingSegmentsMembermrk:PharmaceuticalsegmentMembermrk:InternationalMembermrk:KeytrudaMember2020-01-012020-09-300000310158us-gaap:OperatingSegmentsMembermrk:PharmaceuticalsegmentMembermrk:KeytrudaMember2020-01-012020-09-300000310158us-gaap:OperatingSegmentsMembercountry:USmrk:PharmaceuticalsegmentMembermrk:KeytrudaMember2019-01-012019-09-300000310158us-gaap:OperatingSegmentsMembermrk:PharmaceuticalsegmentMembermrk:InternationalMembermrk:KeytrudaMember2019-01-012019-09-300000310158us-gaap:OperatingSegmentsMembermrk:PharmaceuticalsegmentMembermrk:KeytrudaMember2019-01-012019-09-300000310158us-gaap:OperatingSegmentsMembercountry:USmrk:PharmaceuticalsegmentMembermrk:AlliancerevenueLynparzaMember2020-07-012020-09-300000310158us-gaap:OperatingSegmentsMembermrk:PharmaceuticalsegmentMembermrk:AlliancerevenueLynparzaMembermrk:InternationalMember2020-07-012020-09-300000310158us-gaap:OperatingSegmentsMembermrk:PharmaceuticalsegmentMembermrk:AlliancerevenueLynparzaMember2020-07-012020-09-300000310158us-gaap:OperatingSegmentsMembercountry:USmrk:PharmaceuticalsegmentMembermrk:AlliancerevenueLynparzaMember2019-07-012019-09-300000310158us-gaap:OperatingSegmentsMembermrk:PharmaceuticalsegmentMembermrk:AlliancerevenueLynparzaMembermrk:InternationalMember2019-07-012019-09-300000310158us-gaap:OperatingSegmentsMembermrk:PharmaceuticalsegmentMembermrk:AlliancerevenueLynparzaMember2019-07-012019-09-300000310158us-gaap:OperatingSegmentsMembercountry:USmrk:PharmaceuticalsegmentMembermrk:AlliancerevenueLynparzaMember2020-01-012020-09-300000310158us-gaap:OperatingSegmentsMembermrk:PharmaceuticalsegmentMembermrk:AlliancerevenueLynparzaMembermrk:InternationalMember2020-01-012020-09-300000310158us-gaap:OperatingSegmentsMembermrk:PharmaceuticalsegmentMembermrk:AlliancerevenueLynparzaMember2020-01-012020-09-300000310158us-gaap:OperatingSegmentsMembercountry:USmrk:PharmaceuticalsegmentMembermrk:AlliancerevenueLynparzaMember2019-01-012019-09-300000310158us-gaap:OperatingSegmentsMembermrk:PharmaceuticalsegmentMembermrk:AlliancerevenueLynparzaMembermrk:InternationalMember2019-01-012019-09-300000310158us-gaap:OperatingSegmentsMembermrk:PharmaceuticalsegmentMembermrk:AlliancerevenueLynparzaMember2019-01-012019-09-300000310158us-gaap:OperatingSegmentsMembercountry:USmrk:PharmaceuticalsegmentMembermrk:LenvimaMember2020-07-012020-09-300000310158us-gaap:OperatingSegmentsMembermrk:PharmaceuticalsegmentMembermrk:LenvimaMembermrk:InternationalMember2020-07-012020-09-300000310158us-gaap:OperatingSegmentsMembermrk:PharmaceuticalsegmentMembermrk:LenvimaMember2020-07-012020-09-300000310158us-gaap:OperatingSegmentsMembercountry:USmrk:PharmaceuticalsegmentMembermrk:LenvimaMember2019-07-012019-09-300000310158us-gaap:OperatingSegmentsMembermrk:PharmaceuticalsegmentMembermrk:LenvimaMembermrk:InternationalMember2019-07-012019-09-300000310158us-gaap:OperatingSegmentsMembermrk:PharmaceuticalsegmentMembermrk:LenvimaMember2019-07-012019-09-300000310158us-gaap:OperatingSegmentsMembercountry:USmrk:PharmaceuticalsegmentMembermrk:LenvimaMember2020-01-012020-09-300000310158us-gaap:OperatingSegmentsMembermrk:PharmaceuticalsegmentMembermrk:LenvimaMembermrk:InternationalMember2020-01-012020-09-300000310158us-gaap:OperatingSegmentsMembermrk:PharmaceuticalsegmentMembermrk:LenvimaMember2020-01-012020-09-300000310158us-gaap:OperatingSegmentsMembercountry:USmrk:PharmaceuticalsegmentMembermrk:LenvimaMember2019-01-012019-09-300000310158us-gaap:OperatingSegmentsMembermrk:PharmaceuticalsegmentMembermrk:LenvimaMembermrk:InternationalMember2019-01-012019-09-300000310158us-gaap:OperatingSegmentsMembermrk:PharmaceuticalsegmentMembermrk:LenvimaMember2019-01-012019-09-300000310158us-gaap:OperatingSegmentsMembercountry:USmrk:PharmaceuticalsegmentMembermrk:EmendMember2020-07-012020-09-300000310158us-gaap:OperatingSegmentsMembermrk:PharmaceuticalsegmentMembermrk:InternationalMembermrk:EmendMember2020-07-012020-09-300000310158us-gaap:OperatingSegmentsMembermrk:PharmaceuticalsegmentMembermrk:EmendMember2020-07-012020-09-300000310158us-gaap:OperatingSegmentsMembercountry:USmrk:PharmaceuticalsegmentMembermrk:EmendMember2019-07-012019-09-300000310158us-gaap:OperatingSegmentsMembermrk:PharmaceuticalsegmentMembermrk:InternationalMembermrk:EmendMember2019-07-012019-09-300000310158us-gaap:OperatingSegmentsMembermrk:PharmaceuticalsegmentMembermrk:EmendMember2019-07-012019-09-300000310158us-gaap:OperatingSegmentsMembercountry:USmrk:PharmaceuticalsegmentMembermrk:EmendMember2020-01-012020-09-300000310158us-gaap:OperatingSegmentsMembermrk:PharmaceuticalsegmentMembermrk:InternationalMembermrk:EmendMember2020-01-012020-09-300000310158us-gaap:OperatingSegmentsMembermrk:PharmaceuticalsegmentMembermrk:EmendMember2020-01-012020-09-300000310158us-gaap:OperatingSegmentsMembercountry:USmrk:PharmaceuticalsegmentMembermrk:EmendMember2019-01-012019-09-300000310158us-gaap:OperatingSegmentsMembermrk:PharmaceuticalsegmentMembermrk:InternationalMembermrk:EmendMember2019-01-012019-09-300000310158us-gaap:OperatingSegmentsMembermrk:PharmaceuticalsegmentMembermrk:EmendMember2019-01-012019-09-300000310158us-gaap:OperatingSegmentsMembermrk:GardasilGardasil9Membercountry:USmrk:PharmaceuticalsegmentMember2020-07-012020-09-300000310158us-gaap:OperatingSegmentsMembermrk:GardasilGardasil9Membermrk:PharmaceuticalsegmentMembermrk:InternationalMember2020-07-012020-09-300000310158us-gaap:OperatingSegmentsMembermrk:GardasilGardasil9Membermrk:PharmaceuticalsegmentMember2020-07-012020-09-300000310158us-gaap:OperatingSegmentsMembermrk:GardasilGardasil9Membercountry:USmrk:PharmaceuticalsegmentMember2019-07-012019-09-300000310158us-gaap:OperatingSegmentsMembermrk:GardasilGardasil9Membermrk:PharmaceuticalsegmentMembermrk:InternationalMember2019-07-012019-09-300000310158us-gaap:OperatingSegmentsMembermrk:GardasilGardasil9Membermrk:PharmaceuticalsegmentMember2019-07-012019-09-300000310158us-gaap:OperatingSegmentsMembermrk:GardasilGardasil9Membercountry:USmrk:PharmaceuticalsegmentMember2020-01-012020-09-300000310158us-gaap:OperatingSegmentsMembermrk:GardasilGardasil9Membermrk:PharmaceuticalsegmentMembermrk:InternationalMember2020-01-012020-09-300000310158us-gaap:OperatingSegmentsMembermrk:GardasilGardasil9Membermrk:PharmaceuticalsegmentMember2020-01-012020-09-300000310158us-gaap:OperatingSegmentsMembermrk:GardasilGardasil9Membercountry:USmrk:PharmaceuticalsegmentMember2019-01-012019-09-300000310158us-gaap:OperatingSegmentsMembermrk:GardasilGardasil9Membermrk:PharmaceuticalsegmentMembermrk:InternationalMember2019-01-012019-09-300000310158us-gaap:OperatingSegmentsMembermrk:GardasilGardasil9Membermrk:PharmaceuticalsegmentMember2019-01-012019-09-300000310158us-gaap:OperatingSegmentsMembermrk:ProQuadMMRIIVarivaxMembercountry:USmrk:PharmaceuticalsegmentMember2020-07-012020-09-300000310158us-gaap:OperatingSegmentsMembermrk:ProQuadMMRIIVarivaxMembermrk:PharmaceuticalsegmentMembermrk:InternationalMember2020-07-012020-09-300000310158us-gaap:OperatingSegmentsMembermrk:ProQuadMMRIIVarivaxMembermrk:PharmaceuticalsegmentMember2020-07-012020-09-300000310158us-gaap:OperatingSegmentsMembermrk:ProQuadMMRIIVarivaxMembercountry:USmrk:PharmaceuticalsegmentMember2019-07-012019-09-300000310158us-gaap:OperatingSegmentsMembermrk:ProQuadMMRIIVarivaxMembermrk:PharmaceuticalsegmentMembermrk:InternationalMember2019-07-012019-09-300000310158us-gaap:OperatingSegmentsMembermrk:ProQuadMMRIIVarivaxMembermrk:PharmaceuticalsegmentMember2019-07-012019-09-300000310158us-gaap:OperatingSegmentsMembermrk:ProQuadMMRIIVarivaxMembercountry:USmrk:PharmaceuticalsegmentMember2020-01-012020-09-300000310158us-gaap:OperatingSegmentsMembermrk:ProQuadMMRIIVarivaxMembermrk:PharmaceuticalsegmentMembermrk:InternationalMember2020-01-012020-09-300000310158us-gaap:OperatingSegmentsMembermrk:ProQuadMMRIIVarivaxMembermrk:PharmaceuticalsegmentMember2020-01-012020-09-300000310158us-gaap:OperatingSegmentsMembermrk:ProQuadMMRIIVarivaxMembercountry:USmrk:PharmaceuticalsegmentMember2019-01-012019-09-300000310158us-gaap:OperatingSegmentsMembermrk:ProQuadMMRIIVarivaxMembermrk:PharmaceuticalsegmentMembermrk:InternationalMember2019-01-012019-09-300000310158us-gaap:OperatingSegmentsMembermrk:ProQuadMMRIIVarivaxMembermrk:PharmaceuticalsegmentMember2019-01-012019-09-300000310158us-gaap:OperatingSegmentsMembercountry:USmrk:PharmaceuticalsegmentMembermrk:Pneumovax23Member2020-07-012020-09-300000310158us-gaap:OperatingSegmentsMembermrk:PharmaceuticalsegmentMembermrk:Pneumovax23Membermrk:InternationalMember2020-07-012020-09-300000310158us-gaap:OperatingSegmentsMembermrk:PharmaceuticalsegmentMembermrk:Pneumovax23Member2020-07-012020-09-300000310158us-gaap:OperatingSegmentsMembercountry:USmrk:PharmaceuticalsegmentMembermrk:Pneumovax23Member2019-07-012019-09-300000310158us-gaap:OperatingSegmentsMembermrk:PharmaceuticalsegmentMembermrk:Pneumovax23Membermrk:InternationalMember2019-07-012019-09-300000310158us-gaap:OperatingSegmentsMembermrk:PharmaceuticalsegmentMembermrk:Pneumovax23Member2019-07-012019-09-300000310158us-gaap:OperatingSegmentsMembercountry:USmrk:PharmaceuticalsegmentMembermrk:Pneumovax23Member2020-01-012020-09-300000310158us-gaap:OperatingSegmentsMembermrk:PharmaceuticalsegmentMembermrk:Pneumovax23Membermrk:InternationalMember2020-01-012020-09-300000310158us-gaap:OperatingSegmentsMembermrk:PharmaceuticalsegmentMembermrk:Pneumovax23Member2020-01-012020-09-300000310158us-gaap:OperatingSegmentsMembercountry:USmrk:PharmaceuticalsegmentMembermrk:Pneumovax23Member2019-01-012019-09-300000310158us-gaap:OperatingSegmentsMembermrk:PharmaceuticalsegmentMembermrk:Pneumovax23Membermrk:InternationalMember2019-01-012019-09-300000310158us-gaap:OperatingSegmentsMembermrk:PharmaceuticalsegmentMembermrk:Pneumovax23Member2019-01-012019-09-300000310158us-gaap:OperatingSegmentsMembercountry:USmrk:PharmaceuticalsegmentMembermrk:RotateqMember2020-07-012020-09-300000310158us-gaap:OperatingSegmentsMembermrk:PharmaceuticalsegmentMembermrk:RotateqMembermrk:InternationalMember2020-07-012020-09-300000310158us-gaap:OperatingSegmentsMembermrk:PharmaceuticalsegmentMembermrk:RotateqMember2020-07-012020-09-300000310158us-gaap:OperatingSegmentsMembercountry:USmrk:PharmaceuticalsegmentMembermrk:RotateqMember2019-07-012019-09-300000310158us-gaap:OperatingSegmentsMembermrk:PharmaceuticalsegmentMembermrk:RotateqMembermrk:InternationalMember2019-07-012019-09-300000310158us-gaap:OperatingSegmentsMembermrk:PharmaceuticalsegmentMembermrk:RotateqMember2019-07-012019-09-300000310158us-gaap:OperatingSegmentsMembercountry:USmrk:PharmaceuticalsegmentMembermrk:RotateqMember2020-01-012020-09-300000310158us-gaap:OperatingSegmentsMembermrk:PharmaceuticalsegmentMembermrk:RotateqMembermrk:InternationalMember2020-01-012020-09-300000310158us-gaap:OperatingSegmentsMembermrk:PharmaceuticalsegmentMembermrk:RotateqMember2020-01-012020-09-300000310158us-gaap:OperatingSegmentsMembercountry:USmrk:PharmaceuticalsegmentMembermrk:RotateqMember2019-01-012019-09-300000310158us-gaap:OperatingSegmentsMembermrk:PharmaceuticalsegmentMembermrk:RotateqMembermrk:InternationalMember2019-01-012019-09-300000310158us-gaap:OperatingSegmentsMembermrk:PharmaceuticalsegmentMembermrk:RotateqMember2019-01-012019-09-300000310158us-gaap:OperatingSegmentsMembercountry:USmrk:PharmaceuticalsegmentMembermrk:VaqtaMember2020-07-012020-09-300000310158us-gaap:OperatingSegmentsMembermrk:PharmaceuticalsegmentMembermrk:VaqtaMembermrk:InternationalMember2020-07-012020-09-300000310158us-gaap:OperatingSegmentsMembermrk:PharmaceuticalsegmentMembermrk:VaqtaMember2020-07-012020-09-300000310158us-gaap:OperatingSegmentsMembercountry:USmrk:PharmaceuticalsegmentMembermrk:VaqtaMember2019-07-012019-09-300000310158us-gaap:OperatingSegmentsMembermrk:PharmaceuticalsegmentMembermrk:VaqtaMembermrk:InternationalMember2019-07-012019-09-300000310158us-gaap:OperatingSegmentsMembermrk:PharmaceuticalsegmentMembermrk:VaqtaMember2019-07-012019-09-300000310158us-gaap:OperatingSegmentsMembercountry:USmrk:PharmaceuticalsegmentMembermrk:VaqtaMember2020-01-012020-09-300000310158us-gaap:OperatingSegmentsMembermrk:PharmaceuticalsegmentMembermrk:VaqtaMembermrk:InternationalMember2020-01-012020-09-300000310158us-gaap:OperatingSegmentsMembermrk:PharmaceuticalsegmentMembermrk:VaqtaMember2020-01-012020-09-300000310158us-gaap:OperatingSegmentsMembercountry:USmrk:PharmaceuticalsegmentMembermrk:VaqtaMember2019-01-012019-09-300000310158us-gaap:OperatingSegmentsMembermrk:PharmaceuticalsegmentMembermrk:VaqtaMembermrk:InternationalMember2019-01-012019-09-300000310158us-gaap:OperatingSegmentsMembermrk:PharmaceuticalsegmentMembermrk:VaqtaMember2019-01-012019-09-300000310158us-gaap:OperatingSegmentsMembermrk:BridionMembercountry:USmrk:PharmaceuticalsegmentMember2020-07-012020-09-300000310158us-gaap:OperatingSegmentsMembermrk:BridionMembermrk:PharmaceuticalsegmentMembermrk:InternationalMember2020-07-012020-09-300000310158us-gaap:OperatingSegmentsMembermrk:BridionMembermrk:PharmaceuticalsegmentMember2020-07-012020-09-300000310158us-gaap:OperatingSegmentsMembermrk:BridionMembercountry:USmrk:PharmaceuticalsegmentMember2019-07-012019-09-300000310158us-gaap:OperatingSegmentsMembermrk:BridionMembermrk:PharmaceuticalsegmentMembermrk:InternationalMember2019-07-012019-09-300000310158us-gaap:OperatingSegmentsMembermrk:BridionMembermrk:PharmaceuticalsegmentMember2019-07-012019-09-300000310158us-gaap:OperatingSegmentsMembermrk:BridionMembercountry:USmrk:PharmaceuticalsegmentMember2020-01-012020-09-300000310158us-gaap:OperatingSegmentsMembermrk:BridionMembermrk:PharmaceuticalsegmentMembermrk:InternationalMember2020-01-012020-09-300000310158us-gaap:OperatingSegmentsMembermrk:BridionMembermrk:PharmaceuticalsegmentMember2020-01-012020-09-300000310158us-gaap:OperatingSegmentsMembermrk:BridionMembercountry:USmrk:PharmaceuticalsegmentMember2019-01-012019-09-300000310158us-gaap:OperatingSegmentsMembermrk:BridionMembermrk:PharmaceuticalsegmentMembermrk:InternationalMember2019-01-012019-09-300000310158us-gaap:OperatingSegmentsMembermrk:BridionMembermrk:PharmaceuticalsegmentMember2019-01-012019-09-300000310158us-gaap:OperatingSegmentsMembermrk:NoxafilMembercountry:USmrk:PharmaceuticalsegmentMember2020-07-012020-09-300000310158us-gaap:OperatingSegmentsMembermrk:NoxafilMembermrk:PharmaceuticalsegmentMembermrk:InternationalMember2020-07-012020-09-300000310158us-gaap:OperatingSegmentsMembermrk:NoxafilMembermrk:PharmaceuticalsegmentMember2020-07-012020-09-300000310158us-gaap:OperatingSegmentsMembermrk:NoxafilMembercountry:USmrk:PharmaceuticalsegmentMember2019-07-012019-09-300000310158us-gaap:OperatingSegmentsMembermrk:NoxafilMembermrk:PharmaceuticalsegmentMembermrk:InternationalMember2019-07-012019-09-300000310158us-gaap:OperatingSegmentsMembermrk:NoxafilMembermrk:PharmaceuticalsegmentMember2019-07-012019-09-300000310158us-gaap:OperatingSegmentsMembermrk:NoxafilMembercountry:USmrk:PharmaceuticalsegmentMember2020-01-012020-09-300000310158us-gaap:OperatingSegmentsMembermrk:NoxafilMembermrk:PharmaceuticalsegmentMembermrk:InternationalMember2020-01-012020-09-300000310158us-gaap:OperatingSegmentsMembermrk:NoxafilMembermrk:PharmaceuticalsegmentMember2020-01-012020-09-300000310158us-gaap:OperatingSegmentsMembermrk:NoxafilMembercountry:USmrk:PharmaceuticalsegmentMember2019-01-012019-09-300000310158us-gaap:OperatingSegmentsMembermrk:NoxafilMembermrk:PharmaceuticalsegmentMembermrk:InternationalMember2019-01-012019-09-300000310158us-gaap:OperatingSegmentsMembermrk:NoxafilMembermrk:PharmaceuticalsegmentMember2019-01-012019-09-300000310158us-gaap:OperatingSegmentsMembercountry:USmrk:PharmaceuticalsegmentMembermrk:PrevymisMember2020-07-012020-09-300000310158us-gaap:OperatingSegmentsMembermrk:PharmaceuticalsegmentMembermrk:PrevymisMembermrk:InternationalMember2020-07-012020-09-300000310158us-gaap:OperatingSegmentsMembermrk:PharmaceuticalsegmentMembermrk:PrevymisMember2020-07-012020-09-300000310158us-gaap:OperatingSegmentsMembercountry:USmrk:PharmaceuticalsegmentMembermrk:PrevymisMember2019-07-012019-09-300000310158us-gaap:OperatingSegmentsMembermrk:PharmaceuticalsegmentMembermrk:PrevymisMembermrk:InternationalMember2019-07-012019-09-300000310158us-gaap:OperatingSegmentsMembermrk:PharmaceuticalsegmentMembermrk:PrevymisMember2019-07-012019-09-300000310158us-gaap:OperatingSegmentsMembercountry:USmrk:PharmaceuticalsegmentMembermrk:PrevymisMember2020-01-012020-09-300000310158us-gaap:OperatingSegmentsMembermrk:PharmaceuticalsegmentMembermrk:PrevymisMembermrk:InternationalMember2020-01-012020-09-300000310158us-gaap:OperatingSegmentsMembermrk:PharmaceuticalsegmentMembermrk:PrevymisMember2020-01-012020-09-300000310158us-gaap:OperatingSegmentsMembercountry:USmrk:PharmaceuticalsegmentMembermrk:PrevymisMember2019-01-012019-09-300000310158us-gaap:OperatingSegmentsMembermrk:PharmaceuticalsegmentMembermrk:PrevymisMembermrk:InternationalMember2019-01-012019-09-300000310158us-gaap:OperatingSegmentsMembermrk:PharmaceuticalsegmentMembermrk:PrevymisMember2019-01-012019-09-300000310158us-gaap:OperatingSegmentsMembermrk:PrimaxinMembercountry:USmrk:PharmaceuticalsegmentMember2020-07-012020-09-300000310158us-gaap:OperatingSegmentsMembermrk:PrimaxinMembermrk:PharmaceuticalsegmentMembermrk:InternationalMember2020-07-012020-09-300000310158us-gaap:OperatingSegmentsMembermrk:PrimaxinMembermrk:PharmaceuticalsegmentMember2020-07-012020-09-300000310158us-gaap:OperatingSegmentsMembermrk:PrimaxinMembercountry:USmrk:PharmaceuticalsegmentMember2019-07-012019-09-300000310158us-gaap:OperatingSegmentsMembermrk:PrimaxinMembermrk:PharmaceuticalsegmentMembermrk:InternationalMember2019-07-012019-09-300000310158us-gaap:OperatingSegmentsMembermrk:PrimaxinMembermrk:PharmaceuticalsegmentMember2019-07-012019-09-300000310158us-gaap:OperatingSegmentsMembermrk:PrimaxinMembercountry:USmrk:PharmaceuticalsegmentMember2020-01-012020-09-300000310158us-gaap:OperatingSegmentsMembermrk:PrimaxinMembermrk:PharmaceuticalsegmentMembermrk:InternationalMember2020-01-012020-09-300000310158us-gaap:OperatingSegmentsMembermrk:PrimaxinMembermrk:PharmaceuticalsegmentMember2020-01-012020-09-300000310158us-gaap:OperatingSegmentsMembermrk:PrimaxinMembercountry:USmrk:PharmaceuticalsegmentMember2019-01-012019-09-300000310158us-gaap:OperatingSegmentsMembermrk:PrimaxinMembermrk:PharmaceuticalsegmentMembermrk:InternationalMember2019-01-012019-09-300000310158us-gaap:OperatingSegmentsMembermrk:PrimaxinMembermrk:PharmaceuticalsegmentMember2019-01-012019-09-300000310158us-gaap:OperatingSegmentsMembercountry:USmrk:PharmaceuticalsegmentMembermrk:InvanzMember2020-07-012020-09-300000310158us-gaap:OperatingSegmentsMembermrk:PharmaceuticalsegmentMembermrk:InvanzMembermrk:InternationalMember2020-07-012020-09-300000310158us-gaap:OperatingSegmentsMembermrk:PharmaceuticalsegmentMembermrk:InvanzMember2020-07-012020-09-300000310158us-gaap:OperatingSegmentsMembercountry:USmrk:PharmaceuticalsegmentMembermrk:InvanzMember2019-07-012019-09-300000310158us-gaap:OperatingSegmentsMembermrk:PharmaceuticalsegmentMembermrk:InvanzMembermrk:InternationalMember2019-07-012019-09-300000310158us-gaap:OperatingSegmentsMembermrk:PharmaceuticalsegmentMembermrk:InvanzMember2019-07-012019-09-300000310158us-gaap:OperatingSegmentsMembercountry:USmrk:PharmaceuticalsegmentMembermrk:InvanzMember2020-01-012020-09-300000310158us-gaap:OperatingSegmentsMembermrk:PharmaceuticalsegmentMembermrk:InvanzMembermrk:InternationalMember2020-01-012020-09-300000310158us-gaap:OperatingSegmentsMembermrk:PharmaceuticalsegmentMembermrk:InvanzMember2020-01-012020-09-300000310158us-gaap:OperatingSegmentsMembercountry:USmrk:PharmaceuticalsegmentMembermrk:InvanzMember2019-01-012019-09-300000310158us-gaap:OperatingSegmentsMembermrk:PharmaceuticalsegmentMembermrk:InvanzMembermrk:InternationalMember2019-01-012019-09-300000310158us-gaap:OperatingSegmentsMembermrk:PharmaceuticalsegmentMembermrk:InvanzMember2019-01-012019-09-300000310158us-gaap:OperatingSegmentsMembercountry:USmrk:PharmaceuticalsegmentMembermrk:CancidasMember2020-07-012020-09-300000310158us-gaap:OperatingSegmentsMembermrk:PharmaceuticalsegmentMembermrk:CancidasMembermrk:InternationalMember2020-07-012020-09-300000310158us-gaap:OperatingSegmentsMembermrk:PharmaceuticalsegmentMembermrk:CancidasMember2020-07-012020-09-300000310158us-gaap:OperatingSegmentsMembercountry:USmrk:PharmaceuticalsegmentMembermrk:CancidasMember2019-07-012019-09-300000310158us-gaap:OperatingSegmentsMembermrk:PharmaceuticalsegmentMembermrk:CancidasMembermrk:InternationalMember2019-07-012019-09-300000310158us-gaap:OperatingSegmentsMembermrk:PharmaceuticalsegmentMembermrk:CancidasMember2019-07-012019-09-300000310158us-gaap:OperatingSegmentsMembercountry:USmrk:PharmaceuticalsegmentMembermrk:CancidasMember2020-01-012020-09-300000310158us-gaap:OperatingSegmentsMembermrk:PharmaceuticalsegmentMembermrk:CancidasMembermrk:InternationalMember2020-01-012020-09-300000310158us-gaap:OperatingSegmentsMembermrk:PharmaceuticalsegmentMembermrk:CancidasMember2020-01-012020-09-300000310158us-gaap:OperatingSegmentsMembercountry:USmrk:PharmaceuticalsegmentMembermrk:CancidasMember2019-01-012019-09-300000310158us-gaap:OperatingSegmentsMembermrk:PharmaceuticalsegmentMembermrk:CancidasMembermrk:InternationalMember2019-01-012019-09-300000310158us-gaap:OperatingSegmentsMembermrk:PharmaceuticalsegmentMembermrk:CancidasMember2019-01-012019-09-300000310158us-gaap:OperatingSegmentsMembercountry:USmrk:PharmaceuticalsegmentMembermrk:CubicinMember2020-07-012020-09-300000310158us-gaap:OperatingSegmentsMembermrk:PharmaceuticalsegmentMembermrk:InternationalMembermrk:CubicinMember2020-07-012020-09-300000310158us-gaap:OperatingSegmentsMembermrk:PharmaceuticalsegmentMembermrk:CubicinMember2020-07-012020-09-300000310158us-gaap:OperatingSegmentsMembercountry:USmrk:PharmaceuticalsegmentMembermrk:CubicinMember2019-07-012019-09-300000310158us-gaap:OperatingSegmentsMembermrk:PharmaceuticalsegmentMembermrk:InternationalMembermrk:CubicinMember2019-07-012019-09-300000310158us-gaap:OperatingSegmentsMembermrk:PharmaceuticalsegmentMembermrk:CubicinMember2019-07-012019-09-300000310158us-gaap:OperatingSegmentsMembercountry:USmrk:PharmaceuticalsegmentMembermrk:CubicinMember2020-01-012020-09-300000310158us-gaap:OperatingSegmentsMembermrk:PharmaceuticalsegmentMembermrk:InternationalMembermrk:CubicinMember2020-01-012020-09-300000310158us-gaap:OperatingSegmentsMembermrk:PharmaceuticalsegmentMembermrk:CubicinMember2020-01-012020-09-300000310158us-gaap:OperatingSegmentsMembercountry:USmrk:PharmaceuticalsegmentMembermrk:CubicinMember2019-01-012019-09-300000310158us-gaap:OperatingSegmentsMembermrk:PharmaceuticalsegmentMembermrk:InternationalMembermrk:CubicinMember2019-01-012019-09-300000310158us-gaap:OperatingSegmentsMembermrk:PharmaceuticalsegmentMembermrk:CubicinMember2019-01-012019-09-300000310158us-gaap:OperatingSegmentsMembermrk:ZerbaxaMembercountry:USmrk:PharmaceuticalsegmentMember2020-07-012020-09-300000310158us-gaap:OperatingSegmentsMembermrk:ZerbaxaMembermrk:PharmaceuticalsegmentMembermrk:InternationalMember2020-07-012020-09-300000310158us-gaap:OperatingSegmentsMembermrk:ZerbaxaMembermrk:PharmaceuticalsegmentMember2020-07-012020-09-300000310158us-gaap:OperatingSegmentsMembermrk:ZerbaxaMembercountry:USmrk:PharmaceuticalsegmentMember2019-07-012019-09-300000310158us-gaap:OperatingSegmentsMembermrk:ZerbaxaMembermrk:PharmaceuticalsegmentMembermrk:InternationalMember2019-07-012019-09-300000310158us-gaap:OperatingSegmentsMembermrk:ZerbaxaMembermrk:PharmaceuticalsegmentMember2019-07-012019-09-300000310158us-gaap:OperatingSegmentsMembermrk:ZerbaxaMembercountry:USmrk:PharmaceuticalsegmentMember2020-01-012020-09-300000310158us-gaap:OperatingSegmentsMembermrk:ZerbaxaMembermrk:PharmaceuticalsegmentMembermrk:InternationalMember2020-01-012020-09-300000310158us-gaap:OperatingSegmentsMembermrk:ZerbaxaMembermrk:PharmaceuticalsegmentMember2020-01-012020-09-300000310158us-gaap:OperatingSegmentsMembermrk:ZerbaxaMembercountry:USmrk:PharmaceuticalsegmentMember2019-01-012019-09-300000310158us-gaap:OperatingSegmentsMembermrk:ZerbaxaMembermrk:PharmaceuticalsegmentMembermrk:InternationalMember2019-01-012019-09-300000310158us-gaap:OperatingSegmentsMembermrk:ZerbaxaMembermrk:PharmaceuticalsegmentMember2019-01-012019-09-300000310158us-gaap:OperatingSegmentsMembercountry:USmrk:PharmaceuticalsegmentMembermrk:SimponiMember2020-07-012020-09-300000310158us-gaap:OperatingSegmentsMembermrk:PharmaceuticalsegmentMembermrk:InternationalMembermrk:SimponiMember2020-07-012020-09-300000310158us-gaap:OperatingSegmentsMembermrk:PharmaceuticalsegmentMembermrk:SimponiMember2020-07-012020-09-300000310158us-gaap:OperatingSegmentsMembercountry:USmrk:PharmaceuticalsegmentMembermrk:SimponiMember2019-07-012019-09-300000310158us-gaap:OperatingSegmentsMembermrk:PharmaceuticalsegmentMembermrk:InternationalMembermrk:SimponiMember2019-07-012019-09-300000310158us-gaap:OperatingSegmentsMembermrk:PharmaceuticalsegmentMembermrk:SimponiMember2019-07-012019-09-300000310158us-gaap:OperatingSegmentsMembercountry:USmrk:PharmaceuticalsegmentMembermrk:SimponiMember2020-01-012020-09-300000310158us-gaap:OperatingSegmentsMembermrk:PharmaceuticalsegmentMembermrk:InternationalMembermrk:SimponiMember2020-01-012020-09-300000310158us-gaap:OperatingSegmentsMembermrk:PharmaceuticalsegmentMembermrk:SimponiMember2020-01-012020-09-300000310158us-gaap:OperatingSegmentsMembercountry:USmrk:PharmaceuticalsegmentMembermrk:SimponiMember2019-01-012019-09-300000310158us-gaap:OperatingSegmentsMembermrk:PharmaceuticalsegmentMembermrk:InternationalMembermrk:SimponiMember2019-01-012019-09-300000310158us-gaap:OperatingSegmentsMembermrk:PharmaceuticalsegmentMembermrk:SimponiMember2019-01-012019-09-300000310158us-gaap:OperatingSegmentsMembermrk:RemicadeMembercountry:USmrk:PharmaceuticalsegmentMember2020-07-012020-09-300000310158us-gaap:OperatingSegmentsMembermrk:RemicadeMembermrk:PharmaceuticalsegmentMembermrk:InternationalMember2020-07-012020-09-300000310158us-gaap:OperatingSegmentsMembermrk:RemicadeMembermrk:PharmaceuticalsegmentMember2020-07-012020-09-300000310158us-gaap:OperatingSegmentsMembermrk:RemicadeMembercountry:USmrk:PharmaceuticalsegmentMember2019-07-012019-09-300000310158us-gaap:OperatingSegmentsMembermrk:RemicadeMembermrk:PharmaceuticalsegmentMembermrk:InternationalMember2019-07-012019-09-300000310158us-gaap:OperatingSegmentsMembermrk:RemicadeMembermrk:PharmaceuticalsegmentMember2019-07-012019-09-300000310158us-gaap:OperatingSegmentsMembermrk:RemicadeMembercountry:USmrk:PharmaceuticalsegmentMember2020-01-012020-09-300000310158us-gaap:OperatingSegmentsMembermrk:RemicadeMembermrk:PharmaceuticalsegmentMembermrk:InternationalMember2020-01-012020-09-300000310158us-gaap:OperatingSegmentsMembermrk:RemicadeMembermrk:PharmaceuticalsegmentMember2020-01-012020-09-300000310158us-gaap:OperatingSegmentsMembermrk:RemicadeMembercountry:USmrk:PharmaceuticalsegmentMember2019-01-012019-09-300000310158us-gaap:OperatingSegmentsMembermrk:RemicadeMembermrk:PharmaceuticalsegmentMembermrk:InternationalMember2019-01-012019-09-300000310158us-gaap:OperatingSegmentsMembermrk:RemicadeMembermrk:PharmaceuticalsegmentMember2019-01-012019-09-300000310158us-gaap:OperatingSegmentsMembercountry:USmrk:PharmaceuticalsegmentMembermrk:BelsomraMember2020-07-012020-09-300000310158us-gaap:OperatingSegmentsMembermrk:PharmaceuticalsegmentMembermrk:BelsomraMembermrk:InternationalMember2020-07-012020-09-300000310158us-gaap:OperatingSegmentsMembermrk:PharmaceuticalsegmentMembermrk:BelsomraMember2020-07-012020-09-300000310158us-gaap:OperatingSegmentsMembercountry:USmrk:PharmaceuticalsegmentMembermrk:BelsomraMember2019-07-012019-09-300000310158us-gaap:OperatingSegmentsMembermrk:PharmaceuticalsegmentMembermrk:BelsomraMembermrk:InternationalMember2019-07-012019-09-300000310158us-gaap:OperatingSegmentsMembermrk:PharmaceuticalsegmentMembermrk:BelsomraMember2019-07-012019-09-300000310158us-gaap:OperatingSegmentsMembercountry:USmrk:PharmaceuticalsegmentMembermrk:BelsomraMember2020-01-012020-09-300000310158us-gaap:OperatingSegmentsMembermrk:PharmaceuticalsegmentMembermrk:BelsomraMembermrk:InternationalMember2020-01-012020-09-300000310158us-gaap:OperatingSegmentsMembermrk:PharmaceuticalsegmentMembermrk:BelsomraMember2020-01-012020-09-300000310158us-gaap:OperatingSegmentsMembercountry:USmrk:PharmaceuticalsegmentMembermrk:BelsomraMember2019-01-012019-09-300000310158us-gaap:OperatingSegmentsMembermrk:PharmaceuticalsegmentMembermrk:BelsomraMembermrk:InternationalMember2019-01-012019-09-300000310158us-gaap:OperatingSegmentsMembermrk:PharmaceuticalsegmentMembermrk:BelsomraMember2019-01-012019-09-300000310158us-gaap:OperatingSegmentsMembercountry:USmrk:PharmaceuticalsegmentMembermrk:IsentressIsentressHDMember2020-07-012020-09-300000310158us-gaap:OperatingSegmentsMembermrk:PharmaceuticalsegmentMembermrk:IsentressIsentressHDMembermrk:InternationalMember2020-07-012020-09-300000310158us-gaap:OperatingSegmentsMembermrk:PharmaceuticalsegmentMembermrk:IsentressIsentressHDMember2020-07-012020-09-300000310158us-gaap:OperatingSegmentsMembercountry:USmrk:PharmaceuticalsegmentMembermrk:IsentressIsentressHDMember2019-07-012019-09-300000310158us-gaap:OperatingSegmentsMembermrk:PharmaceuticalsegmentMembermrk:IsentressIsentressHDMembermrk:InternationalMember2019-07-012019-09-300000310158us-gaap:OperatingSegmentsMembermrk:PharmaceuticalsegmentMembermrk:IsentressIsentressHDMember2019-07-012019-09-300000310158us-gaap:OperatingSegmentsMembercountry:USmrk:PharmaceuticalsegmentMembermrk:IsentressIsentressHDMember2020-01-012020-09-300000310158us-gaap:OperatingSegmentsMembermrk:PharmaceuticalsegmentMembermrk:IsentressIsentressHDMembermrk:InternationalMember2020-01-012020-09-300000310158us-gaap:OperatingSegmentsMembermrk:PharmaceuticalsegmentMembermrk:IsentressIsentressHDMember2020-01-012020-09-300000310158us-gaap:OperatingSegmentsMembercountry:USmrk:PharmaceuticalsegmentMembermrk:IsentressIsentressHDMember2019-01-012019-09-300000310158us-gaap:OperatingSegmentsMembermrk:PharmaceuticalsegmentMembermrk:IsentressIsentressHDMembermrk:InternationalMember2019-01-012019-09-300000310158us-gaap:OperatingSegmentsMembermrk:PharmaceuticalsegmentMembermrk:IsentressIsentressHDMember2019-01-012019-09-300000310158us-gaap:OperatingSegmentsMembermrk:ZepatierMembercountry:USmrk:PharmaceuticalsegmentMember2020-07-012020-09-300000310158us-gaap:OperatingSegmentsMembermrk:ZepatierMembermrk:PharmaceuticalsegmentMembermrk:InternationalMember2020-07-012020-09-300000310158us-gaap:OperatingSegmentsMembermrk:ZepatierMembermrk:PharmaceuticalsegmentMember2020-07-012020-09-300000310158us-gaap:OperatingSegmentsMembermrk:ZepatierMembercountry:USmrk:PharmaceuticalsegmentMember2019-07-012019-09-300000310158us-gaap:OperatingSegmentsMembermrk:ZepatierMembermrk:PharmaceuticalsegmentMembermrk:InternationalMember2019-07-012019-09-300000310158us-gaap:OperatingSegmentsMembermrk:ZepatierMembermrk:PharmaceuticalsegmentMember2019-07-012019-09-300000310158us-gaap:OperatingSegmentsMembermrk:ZepatierMembercountry:USmrk:PharmaceuticalsegmentMember2020-01-012020-09-300000310158us-gaap:OperatingSegmentsMembermrk:ZepatierMembermrk:PharmaceuticalsegmentMembermrk:InternationalMember2020-01-012020-09-300000310158us-gaap:OperatingSegmentsMembermrk:ZepatierMembermrk:PharmaceuticalsegmentMember2020-01-012020-09-300000310158us-gaap:OperatingSegmentsMembermrk:ZepatierMembercountry:USmrk:PharmaceuticalsegmentMember2019-01-012019-09-300000310158us-gaap:OperatingSegmentsMembermrk:ZepatierMembermrk:PharmaceuticalsegmentMembermrk:InternationalMember2019-01-012019-09-300000310158us-gaap:OperatingSegmentsMembermrk:ZepatierMembermrk:PharmaceuticalsegmentMember2019-01-012019-09-300000310158us-gaap:OperatingSegmentsMembercountry:USmrk:PharmaceuticalsegmentMembermrk:ZetiaMember2020-07-012020-09-300000310158us-gaap:OperatingSegmentsMembermrk:PharmaceuticalsegmentMembermrk:ZetiaMembermrk:InternationalMember2020-07-012020-09-300000310158us-gaap:OperatingSegmentsMembermrk:PharmaceuticalsegmentMembermrk:ZetiaMember2020-07-012020-09-300000310158us-gaap:OperatingSegmentsMembercountry:USmrk:PharmaceuticalsegmentMembermrk:ZetiaMember2019-07-012019-09-300000310158us-gaap:OperatingSegmentsMembermrk:PharmaceuticalsegmentMembermrk:ZetiaMembermrk:InternationalMember2019-07-012019-09-300000310158us-gaap:OperatingSegmentsMembermrk:PharmaceuticalsegmentMembermrk:ZetiaMember2019-07-012019-09-300000310158us-gaap:OperatingSegmentsMembercountry:USmrk:PharmaceuticalsegmentMembermrk:ZetiaMember2020-01-012020-09-300000310158us-gaap:OperatingSegmentsMembermrk:PharmaceuticalsegmentMembermrk:ZetiaMembermrk:InternationalMember2020-01-012020-09-300000310158us-gaap:OperatingSegmentsMembermrk:PharmaceuticalsegmentMembermrk:ZetiaMember2020-01-012020-09-300000310158us-gaap:OperatingSegmentsMembercountry:USmrk:PharmaceuticalsegmentMembermrk:ZetiaMember2019-01-012019-09-300000310158us-gaap:OperatingSegmentsMembermrk:PharmaceuticalsegmentMembermrk:ZetiaMembermrk:InternationalMember2019-01-012019-09-300000310158us-gaap:OperatingSegmentsMembermrk:PharmaceuticalsegmentMembermrk:ZetiaMember2019-01-012019-09-300000310158us-gaap:OperatingSegmentsMembermrk:VytorinMembercountry:USmrk:PharmaceuticalsegmentMember2020-07-012020-09-300000310158us-gaap:OperatingSegmentsMembermrk:VytorinMembermrk:PharmaceuticalsegmentMembermrk:InternationalMember2020-07-012020-09-300000310158us-gaap:OperatingSegmentsMembermrk:VytorinMembermrk:PharmaceuticalsegmentMember2020-07-012020-09-300000310158us-gaap:OperatingSegmentsMembermrk:VytorinMembercountry:USmrk:PharmaceuticalsegmentMember2019-07-012019-09-300000310158us-gaap:OperatingSegmentsMembermrk:VytorinMembermrk:PharmaceuticalsegmentMembermrk:InternationalMember2019-07-012019-09-300000310158us-gaap:OperatingSegmentsMembermrk:VytorinMembermrk:PharmaceuticalsegmentMember2019-07-012019-09-300000310158us-gaap:OperatingSegmentsMembermrk:VytorinMembercountry:USmrk:PharmaceuticalsegmentMember2020-01-012020-09-300000310158us-gaap:OperatingSegmentsMembermrk:VytorinMembermrk:PharmaceuticalsegmentMembermrk:InternationalMember2020-01-012020-09-300000310158us-gaap:OperatingSegmentsMembermrk:VytorinMembermrk:PharmaceuticalsegmentMember2020-01-012020-09-300000310158us-gaap:OperatingSegmentsMembermrk:VytorinMembercountry:USmrk:PharmaceuticalsegmentMember2019-01-012019-09-300000310158us-gaap:OperatingSegmentsMembermrk:VytorinMembermrk:PharmaceuticalsegmentMembermrk:InternationalMember2019-01-012019-09-300000310158us-gaap:OperatingSegmentsMembermrk:VytorinMembermrk:PharmaceuticalsegmentMember2019-01-012019-09-300000310158us-gaap:OperatingSegmentsMembermrk:AtozetMembercountry:USmrk:PharmaceuticalsegmentMember2020-07-012020-09-300000310158us-gaap:OperatingSegmentsMembermrk:AtozetMembermrk:PharmaceuticalsegmentMembermrk:InternationalMember2020-07-012020-09-300000310158us-gaap:OperatingSegmentsMembermrk:AtozetMembermrk:PharmaceuticalsegmentMember2020-07-012020-09-300000310158us-gaap:OperatingSegmentsMembermrk:AtozetMembercountry:USmrk:PharmaceuticalsegmentMember2019-07-012019-09-300000310158us-gaap:OperatingSegmentsMembermrk:AtozetMembermrk:PharmaceuticalsegmentMembermrk:InternationalMember2019-07-012019-09-300000310158us-gaap:OperatingSegmentsMembermrk:AtozetMembermrk:PharmaceuticalsegmentMember2019-07-012019-09-300000310158us-gaap:OperatingSegmentsMembermrk:AtozetMembercountry:USmrk:PharmaceuticalsegmentMember2020-01-012020-09-300000310158us-gaap:OperatingSegmentsMembermrk:AtozetMembermrk:PharmaceuticalsegmentMembermrk:InternationalMember2020-01-012020-09-300000310158us-gaap:OperatingSegmentsMembermrk:AtozetMembermrk:PharmaceuticalsegmentMember2020-01-012020-09-300000310158us-gaap:OperatingSegmentsMembermrk:AtozetMembercountry:USmrk:PharmaceuticalsegmentMember2019-01-012019-09-300000310158us-gaap:OperatingSegmentsMembermrk:AtozetMembermrk:PharmaceuticalsegmentMembermrk:InternationalMember2019-01-012019-09-300000310158us-gaap:OperatingSegmentsMembermrk:AtozetMembermrk:PharmaceuticalsegmentMember2019-01-012019-09-300000310158us-gaap:OperatingSegmentsMembercountry:USmrk:PharmaceuticalsegmentMembermrk:AllianceRevenueAdempasMember2020-07-012020-09-300000310158us-gaap:OperatingSegmentsMembermrk:PharmaceuticalsegmentMembermrk:AllianceRevenueAdempasMembermrk:InternationalMember2020-07-012020-09-300000310158us-gaap:OperatingSegmentsMembermrk:PharmaceuticalsegmentMembermrk:AllianceRevenueAdempasMember2020-07-012020-09-300000310158us-gaap:OperatingSegmentsMembercountry:USmrk:PharmaceuticalsegmentMembermrk:AllianceRevenueAdempasMember2019-07-012019-09-300000310158us-gaap:OperatingSegmentsMembermrk:PharmaceuticalsegmentMembermrk:AllianceRevenueAdempasMembermrk:InternationalMember2019-07-012019-09-300000310158us-gaap:OperatingSegmentsMembermrk:PharmaceuticalsegmentMembermrk:AllianceRevenueAdempasMember2019-07-012019-09-300000310158us-gaap:OperatingSegmentsMembercountry:USmrk:PharmaceuticalsegmentMembermrk:AllianceRevenueAdempasMember2020-01-012020-09-300000310158us-gaap:OperatingSegmentsMembermrk:PharmaceuticalsegmentMembermrk:AllianceRevenueAdempasMembermrk:InternationalMember2020-01-012020-09-300000310158us-gaap:OperatingSegmentsMembermrk:PharmaceuticalsegmentMembermrk:AllianceRevenueAdempasMember2020-01-012020-09-300000310158us-gaap:OperatingSegmentsMembercountry:USmrk:PharmaceuticalsegmentMembermrk:AllianceRevenueAdempasMember2019-01-012019-09-300000310158us-gaap:OperatingSegmentsMembermrk:PharmaceuticalsegmentMembermrk:AllianceRevenueAdempasMembermrk:InternationalMember2019-01-012019-09-300000310158us-gaap:OperatingSegmentsMembermrk:PharmaceuticalsegmentMembermrk:AllianceRevenueAdempasMember2019-01-012019-09-300000310158us-gaap:OperatingSegmentsMembercountry:USmrk:PharmaceuticalsegmentMembermrk:AdempasMember2020-07-012020-09-300000310158us-gaap:OperatingSegmentsMembermrk:PharmaceuticalsegmentMembermrk:AdempasMembermrk:InternationalMember2020-07-012020-09-300000310158us-gaap:OperatingSegmentsMembermrk:PharmaceuticalsegmentMembermrk:AdempasMember2020-07-012020-09-300000310158us-gaap:OperatingSegmentsMembercountry:USmrk:PharmaceuticalsegmentMembermrk:AdempasMember2019-07-012019-09-300000310158us-gaap:OperatingSegmentsMembermrk:PharmaceuticalsegmentMembermrk:AdempasMembermrk:InternationalMember2019-07-012019-09-300000310158us-gaap:OperatingSegmentsMembermrk:PharmaceuticalsegmentMembermrk:AdempasMember2019-07-012019-09-300000310158us-gaap:OperatingSegmentsMembercountry:USmrk:PharmaceuticalsegmentMembermrk:AdempasMember2020-01-012020-09-300000310158us-gaap:OperatingSegmentsMembermrk:PharmaceuticalsegmentMembermrk:AdempasMembermrk:InternationalMember2020-01-012020-09-300000310158us-gaap:OperatingSegmentsMembermrk:PharmaceuticalsegmentMembermrk:AdempasMember2020-01-012020-09-300000310158us-gaap:OperatingSegmentsMembercountry:USmrk:PharmaceuticalsegmentMembermrk:AdempasMember2019-01-012019-09-300000310158us-gaap:OperatingSegmentsMembermrk:PharmaceuticalsegmentMembermrk:AdempasMembermrk:InternationalMember2019-01-012019-09-300000310158us-gaap:OperatingSegmentsMembermrk:PharmaceuticalsegmentMembermrk:AdempasMember2019-01-012019-09-300000310158us-gaap:OperatingSegmentsMembermrk:JanuviaMembercountry:USmrk:PharmaceuticalsegmentMember2020-07-012020-09-300000310158us-gaap:OperatingSegmentsMembermrk:JanuviaMembermrk:PharmaceuticalsegmentMembermrk:InternationalMember2020-07-012020-09-300000310158us-gaap:OperatingSegmentsMembermrk:JanuviaMembermrk:PharmaceuticalsegmentMember2020-07-012020-09-300000310158us-gaap:OperatingSegmentsMembermrk:JanuviaMembercountry:USmrk:PharmaceuticalsegmentMember2019-07-012019-09-300000310158us-gaap:OperatingSegmentsMembermrk:JanuviaMembermrk:PharmaceuticalsegmentMembermrk:InternationalMember2019-07-012019-09-300000310158us-gaap:OperatingSegmentsMembermrk:JanuviaMembermrk:PharmaceuticalsegmentMember2019-07-012019-09-300000310158us-gaap:OperatingSegmentsMembermrk:JanuviaMembercountry:USmrk:PharmaceuticalsegmentMember2020-01-012020-09-300000310158us-gaap:OperatingSegmentsMembermrk:JanuviaMembermrk:PharmaceuticalsegmentMembermrk:InternationalMember2020-01-012020-09-300000310158us-gaap:OperatingSegmentsMembermrk:JanuviaMembermrk:PharmaceuticalsegmentMember2020-01-012020-09-300000310158us-gaap:OperatingSegmentsMembermrk:JanuviaMembercountry:USmrk:PharmaceuticalsegmentMember2019-01-012019-09-300000310158us-gaap:OperatingSegmentsMembermrk:JanuviaMembermrk:PharmaceuticalsegmentMembermrk:InternationalMember2019-01-012019-09-300000310158us-gaap:OperatingSegmentsMembermrk:JanuviaMembermrk:PharmaceuticalsegmentMember2019-01-012019-09-300000310158us-gaap:OperatingSegmentsMembermrk:JanumetMembercountry:USmrk:PharmaceuticalsegmentMember2020-07-012020-09-300000310158us-gaap:OperatingSegmentsMembermrk:JanumetMembermrk:PharmaceuticalsegmentMembermrk:InternationalMember2020-07-012020-09-300000310158us-gaap:OperatingSegmentsMembermrk:JanumetMembermrk:PharmaceuticalsegmentMember2020-07-012020-09-300000310158us-gaap:OperatingSegmentsMembermrk:JanumetMembercountry:USmrk:PharmaceuticalsegmentMember2019-07-012019-09-300000310158us-gaap:OperatingSegmentsMembermrk:JanumetMembermrk:PharmaceuticalsegmentMembermrk:InternationalMember2019-07-012019-09-300000310158us-gaap:OperatingSegmentsMembermrk:JanumetMembermrk:PharmaceuticalsegmentMember2019-07-012019-09-300000310158us-gaap:OperatingSegmentsMembermrk:JanumetMembercountry:USmrk:PharmaceuticalsegmentMember2020-01-012020-09-300000310158us-gaap:OperatingSegmentsMembermrk:JanumetMembermrk:PharmaceuticalsegmentMembermrk:InternationalMember2020-01-012020-09-300000310158us-gaap:OperatingSegmentsMembermrk:JanumetMembermrk:PharmaceuticalsegmentMember2020-01-012020-09-300000310158us-gaap:OperatingSegmentsMembermrk:JanumetMembercountry:USmrk:PharmaceuticalsegmentMember2019-01-012019-09-300000310158us-gaap:OperatingSegmentsMembermrk:JanumetMembermrk:PharmaceuticalsegmentMembermrk:InternationalMember2019-01-012019-09-300000310158us-gaap:OperatingSegmentsMembermrk:JanumetMembermrk:PharmaceuticalsegmentMember2019-01-012019-09-300000310158us-gaap:OperatingSegmentsMembermrk:ImplanonNexplanonMembercountry:USmrk:PharmaceuticalsegmentMember2020-07-012020-09-300000310158us-gaap:OperatingSegmentsMembermrk:ImplanonNexplanonMembermrk:PharmaceuticalsegmentMembermrk:InternationalMember2020-07-012020-09-300000310158us-gaap:OperatingSegmentsMembermrk:ImplanonNexplanonMembermrk:PharmaceuticalsegmentMember2020-07-012020-09-300000310158us-gaap:OperatingSegmentsMembermrk:ImplanonNexplanonMembercountry:USmrk:PharmaceuticalsegmentMember2019-07-012019-09-300000310158us-gaap:OperatingSegmentsMembermrk:ImplanonNexplanonMembermrk:PharmaceuticalsegmentMembermrk:InternationalMember2019-07-012019-09-300000310158us-gaap:OperatingSegmentsMembermrk:ImplanonNexplanonMembermrk:PharmaceuticalsegmentMember2019-07-012019-09-300000310158us-gaap:OperatingSegmentsMembermrk:ImplanonNexplanonMembercountry:USmrk:PharmaceuticalsegmentMember2020-01-012020-09-300000310158us-gaap:OperatingSegmentsMembermrk:ImplanonNexplanonMembermrk:PharmaceuticalsegmentMembermrk:InternationalMember2020-01-012020-09-300000310158us-gaap:OperatingSegmentsMembermrk:ImplanonNexplanonMembermrk:PharmaceuticalsegmentMember2020-01-012020-09-300000310158us-gaap:OperatingSegmentsMembermrk:ImplanonNexplanonMembercountry:USmrk:PharmaceuticalsegmentMember2019-01-012019-09-300000310158us-gaap:OperatingSegmentsMembermrk:ImplanonNexplanonMembermrk:PharmaceuticalsegmentMembermrk:InternationalMember2019-01-012019-09-300000310158us-gaap:OperatingSegmentsMembermrk:ImplanonNexplanonMembermrk:PharmaceuticalsegmentMember2019-01-012019-09-300000310158us-gaap:OperatingSegmentsMembercountry:USmrk:PharmaceuticalsegmentMembermrk:NuvaringMember2020-07-012020-09-300000310158us-gaap:OperatingSegmentsMembermrk:PharmaceuticalsegmentMembermrk:NuvaringMembermrk:InternationalMember2020-07-012020-09-300000310158us-gaap:OperatingSegmentsMembermrk:PharmaceuticalsegmentMembermrk:NuvaringMember2020-07-012020-09-300000310158us-gaap:OperatingSegmentsMembercountry:USmrk:PharmaceuticalsegmentMembermrk:NuvaringMember2019-07-012019-09-300000310158us-gaap:OperatingSegmentsMembermrk:PharmaceuticalsegmentMembermrk:NuvaringMembermrk:InternationalMember2019-07-012019-09-300000310158us-gaap:OperatingSegmentsMembermrk:PharmaceuticalsegmentMembermrk:NuvaringMember2019-07-012019-09-300000310158us-gaap:OperatingSegmentsMembercountry:USmrk:PharmaceuticalsegmentMembermrk:NuvaringMember2020-01-012020-09-300000310158us-gaap:OperatingSegmentsMembermrk:PharmaceuticalsegmentMembermrk:NuvaringMembermrk:InternationalMember2020-01-012020-09-300000310158us-gaap:OperatingSegmentsMembermrk:PharmaceuticalsegmentMembermrk:NuvaringMember2020-01-012020-09-300000310158us-gaap:OperatingSegmentsMembercountry:USmrk:PharmaceuticalsegmentMembermrk:NuvaringMember2019-01-012019-09-300000310158us-gaap:OperatingSegmentsMembermrk:PharmaceuticalsegmentMembermrk:NuvaringMembermrk:InternationalMember2019-01-012019-09-300000310158us-gaap:OperatingSegmentsMembermrk:PharmaceuticalsegmentMembermrk:NuvaringMember2019-01-012019-09-300000310158us-gaap:OperatingSegmentsMembermrk:SingulairMembercountry:USmrk:PharmaceuticalsegmentMember2020-07-012020-09-300000310158us-gaap:OperatingSegmentsMembermrk:SingulairMembermrk:PharmaceuticalsegmentMembermrk:InternationalMember2020-07-012020-09-300000310158us-gaap:OperatingSegmentsMembermrk:SingulairMembermrk:PharmaceuticalsegmentMember2020-07-012020-09-300000310158us-gaap:OperatingSegmentsMembermrk:SingulairMembercountry:USmrk:PharmaceuticalsegmentMember2019-07-012019-09-300000310158us-gaap:OperatingSegmentsMembermrk:SingulairMembermrk:PharmaceuticalsegmentMembermrk:InternationalMember2019-07-012019-09-300000310158us-gaap:OperatingSegmentsMembermrk:SingulairMembermrk:PharmaceuticalsegmentMember2019-07-012019-09-300000310158us-gaap:OperatingSegmentsMembermrk:SingulairMembercountry:USmrk:PharmaceuticalsegmentMember2020-01-012020-09-300000310158us-gaap:OperatingSegmentsMembermrk:SingulairMembermrk:PharmaceuticalsegmentMembermrk:InternationalMember2020-01-012020-09-300000310158us-gaap:OperatingSegmentsMembermrk:SingulairMembermrk:PharmaceuticalsegmentMember2020-01-012020-09-300000310158us-gaap:OperatingSegmentsMembermrk:SingulairMembercountry:USmrk:PharmaceuticalsegmentMember2019-01-012019-09-300000310158us-gaap:OperatingSegmentsMembermrk:SingulairMembermrk:PharmaceuticalsegmentMembermrk:InternationalMember2019-01-012019-09-300000310158us-gaap:OperatingSegmentsMembermrk:SingulairMembermrk:PharmaceuticalsegmentMember2019-01-012019-09-300000310158us-gaap:OperatingSegmentsMembermrk:NasonexMembercountry:USmrk:PharmaceuticalsegmentMember2020-07-012020-09-300000310158us-gaap:OperatingSegmentsMembermrk:NasonexMembermrk:PharmaceuticalsegmentMembermrk:InternationalMember2020-07-012020-09-300000310158us-gaap:OperatingSegmentsMembermrk:NasonexMembermrk:PharmaceuticalsegmentMember2020-07-012020-09-300000310158us-gaap:OperatingSegmentsMembermrk:NasonexMembercountry:USmrk:PharmaceuticalsegmentMember2019-07-012019-09-300000310158us-gaap:OperatingSegmentsMembermrk:NasonexMembermrk:PharmaceuticalsegmentMembermrk:InternationalMember2019-07-012019-09-300000310158us-gaap:OperatingSegmentsMembermrk:NasonexMembermrk:PharmaceuticalsegmentMember2019-07-012019-09-300000310158us-gaap:OperatingSegmentsMembermrk:NasonexMembercountry:USmrk:PharmaceuticalsegmentMember2020-01-012020-09-300000310158us-gaap:OperatingSegmentsMembermrk:NasonexMembermrk:PharmaceuticalsegmentMembermrk:InternationalMember2020-01-012020-09-300000310158us-gaap:OperatingSegmentsMembermrk:NasonexMembermrk:PharmaceuticalsegmentMember2020-01-012020-09-300000310158us-gaap:OperatingSegmentsMembermrk:NasonexMembercountry:USmrk:PharmaceuticalsegmentMember2019-01-012019-09-300000310158us-gaap:OperatingSegmentsMembermrk:NasonexMembermrk:PharmaceuticalsegmentMembermrk:InternationalMember2019-01-012019-09-300000310158us-gaap:OperatingSegmentsMembermrk:NasonexMembermrk:PharmaceuticalsegmentMember2019-01-012019-09-300000310158us-gaap:OperatingSegmentsMembercountry:USmrk:PharmaceuticalsegmentMembermrk:ArcoxiaMember2020-07-012020-09-300000310158us-gaap:OperatingSegmentsMembermrk:PharmaceuticalsegmentMembermrk:ArcoxiaMembermrk:InternationalMember2020-07-012020-09-300000310158us-gaap:OperatingSegmentsMembermrk:PharmaceuticalsegmentMembermrk:ArcoxiaMember2020-07-012020-09-300000310158us-gaap:OperatingSegmentsMembercountry:USmrk:PharmaceuticalsegmentMembermrk:ArcoxiaMember2019-07-012019-09-300000310158us-gaap:OperatingSegmentsMembermrk:PharmaceuticalsegmentMembermrk:ArcoxiaMembermrk:InternationalMember2019-07-012019-09-300000310158us-gaap:OperatingSegmentsMembermrk:PharmaceuticalsegmentMembermrk:ArcoxiaMember2019-07-012019-09-300000310158us-gaap:OperatingSegmentsMembercountry:USmrk:PharmaceuticalsegmentMembermrk:ArcoxiaMember2020-01-012020-09-300000310158us-gaap:OperatingSegmentsMembermrk:PharmaceuticalsegmentMembermrk:ArcoxiaMembermrk:InternationalMember2020-01-012020-09-300000310158us-gaap:OperatingSegmentsMembermrk:PharmaceuticalsegmentMembermrk:ArcoxiaMember2020-01-012020-09-300000310158us-gaap:OperatingSegmentsMembercountry:USmrk:PharmaceuticalsegmentMembermrk:ArcoxiaMember2019-01-012019-09-300000310158us-gaap:OperatingSegmentsMembermrk:PharmaceuticalsegmentMembermrk:ArcoxiaMembermrk:InternationalMember2019-01-012019-09-300000310158us-gaap:OperatingSegmentsMembermrk:PharmaceuticalsegmentMembermrk:ArcoxiaMember2019-01-012019-09-300000310158us-gaap:OperatingSegmentsMembermrk:CozaarHyzaarMembercountry:USmrk:PharmaceuticalsegmentMember2020-07-012020-09-300000310158us-gaap:OperatingSegmentsMembermrk:CozaarHyzaarMembermrk:PharmaceuticalsegmentMembermrk:InternationalMember2020-07-012020-09-300000310158us-gaap:OperatingSegmentsMembermrk:CozaarHyzaarMembermrk:PharmaceuticalsegmentMember2020-07-012020-09-300000310158us-gaap:OperatingSegmentsMembermrk:CozaarHyzaarMembercountry:USmrk:PharmaceuticalsegmentMember2019-07-012019-09-300000310158us-gaap:OperatingSegmentsMembermrk:CozaarHyzaarMembermrk:PharmaceuticalsegmentMembermrk:InternationalMember2019-07-012019-09-300000310158us-gaap:OperatingSegmentsMembermrk:CozaarHyzaarMembermrk:PharmaceuticalsegmentMember2019-07-012019-09-300000310158us-gaap:OperatingSegmentsMembermrk:CozaarHyzaarMembercountry:USmrk:PharmaceuticalsegmentMember2020-01-012020-09-300000310158us-gaap:OperatingSegmentsMembermrk:CozaarHyzaarMembermrk:PharmaceuticalsegmentMembermrk:InternationalMember2020-01-012020-09-300000310158us-gaap:OperatingSegmentsMembermrk:CozaarHyzaarMembermrk:PharmaceuticalsegmentMember2020-01-012020-09-300000310158us-gaap:OperatingSegmentsMembermrk:CozaarHyzaarMembercountry:USmrk:PharmaceuticalsegmentMember2019-01-012019-09-300000310158us-gaap:OperatingSegmentsMembermrk:CozaarHyzaarMembermrk:PharmaceuticalsegmentMembermrk:InternationalMember2019-01-012019-09-300000310158us-gaap:OperatingSegmentsMembermrk:CozaarHyzaarMembermrk:PharmaceuticalsegmentMember2019-01-012019-09-300000310158us-gaap:OperatingSegmentsMembermrk:FollistimAqMembercountry:USmrk:PharmaceuticalsegmentMember2020-07-012020-09-300000310158us-gaap:OperatingSegmentsMembermrk:FollistimAqMembermrk:PharmaceuticalsegmentMembermrk:InternationalMember2020-07-012020-09-300000310158us-gaap:OperatingSegmentsMembermrk:FollistimAqMembermrk:PharmaceuticalsegmentMember2020-07-012020-09-300000310158us-gaap:OperatingSegmentsMembermrk:FollistimAqMembercountry:USmrk:PharmaceuticalsegmentMember2019-07-012019-09-300000310158us-gaap:OperatingSegmentsMembermrk:FollistimAqMembermrk:PharmaceuticalsegmentMembermrk:InternationalMember2019-07-012019-09-300000310158us-gaap:OperatingSegmentsMembermrk:FollistimAqMembermrk:PharmaceuticalsegmentMember2019-07-012019-09-300000310158us-gaap:OperatingSegmentsMembermrk:FollistimAqMembercountry:USmrk:PharmaceuticalsegmentMember2020-01-012020-09-300000310158us-gaap:OperatingSegmentsMembermrk:FollistimAqMembermrk:PharmaceuticalsegmentMembermrk:InternationalMember2020-01-012020-09-300000310158us-gaap:OperatingSegmentsMembermrk:FollistimAqMembermrk:PharmaceuticalsegmentMember2020-01-012020-09-300000310158us-gaap:OperatingSegmentsMembermrk:FollistimAqMembercountry:USmrk:PharmaceuticalsegmentMember2019-01-012019-09-300000310158us-gaap:OperatingSegmentsMembermrk:FollistimAqMembermrk:PharmaceuticalsegmentMembermrk:InternationalMember2019-01-012019-09-300000310158us-gaap:OperatingSegmentsMembermrk:FollistimAqMembermrk:PharmaceuticalsegmentMember2019-01-012019-09-300000310158us-gaap:OperatingSegmentsMembercountry:USmrk:PharmaceuticalsegmentMembermrk:OtherPharmaceuticalMember2020-07-012020-09-300000310158us-gaap:OperatingSegmentsMembermrk:PharmaceuticalsegmentMembermrk:OtherPharmaceuticalMembermrk:InternationalMember2020-07-012020-09-300000310158us-gaap:OperatingSegmentsMembermrk:PharmaceuticalsegmentMembermrk:OtherPharmaceuticalMember2020-07-012020-09-300000310158us-gaap:OperatingSegmentsMembercountry:USmrk:PharmaceuticalsegmentMembermrk:OtherPharmaceuticalMember2019-07-012019-09-300000310158us-gaap:OperatingSegmentsMembermrk:PharmaceuticalsegmentMembermrk:OtherPharmaceuticalMembermrk:InternationalMember2019-07-012019-09-300000310158us-gaap:OperatingSegmentsMembermrk:PharmaceuticalsegmentMembermrk:OtherPharmaceuticalMember2019-07-012019-09-300000310158us-gaap:OperatingSegmentsMembercountry:USmrk:PharmaceuticalsegmentMembermrk:OtherPharmaceuticalMember2020-01-012020-09-300000310158us-gaap:OperatingSegmentsMembermrk:PharmaceuticalsegmentMembermrk:OtherPharmaceuticalMembermrk:InternationalMember2020-01-012020-09-300000310158us-gaap:OperatingSegmentsMembermrk:PharmaceuticalsegmentMembermrk:OtherPharmaceuticalMember2020-01-012020-09-300000310158us-gaap:OperatingSegmentsMembercountry:USmrk:PharmaceuticalsegmentMembermrk:OtherPharmaceuticalMember2019-01-012019-09-300000310158us-gaap:OperatingSegmentsMembermrk:PharmaceuticalsegmentMembermrk:OtherPharmaceuticalMembermrk:InternationalMember2019-01-012019-09-300000310158us-gaap:OperatingSegmentsMembermrk:PharmaceuticalsegmentMembermrk:OtherPharmaceuticalMember2019-01-012019-09-300000310158us-gaap:OperatingSegmentsMembercountry:USmrk:PharmaceuticalsegmentMember2020-07-012020-09-300000310158us-gaap:OperatingSegmentsMembermrk:PharmaceuticalsegmentMembermrk:InternationalMember2020-07-012020-09-300000310158us-gaap:OperatingSegmentsMembermrk:PharmaceuticalsegmentMember2020-07-012020-09-300000310158us-gaap:OperatingSegmentsMembercountry:USmrk:PharmaceuticalsegmentMember2019-07-012019-09-300000310158us-gaap:OperatingSegmentsMembermrk:PharmaceuticalsegmentMembermrk:InternationalMember2019-07-012019-09-300000310158us-gaap:OperatingSegmentsMembermrk:PharmaceuticalsegmentMember2019-07-012019-09-300000310158us-gaap:OperatingSegmentsMembercountry:USmrk:PharmaceuticalsegmentMember2020-01-012020-09-300000310158us-gaap:OperatingSegmentsMembermrk:PharmaceuticalsegmentMembermrk:InternationalMember2020-01-012020-09-300000310158us-gaap:OperatingSegmentsMembermrk:PharmaceuticalsegmentMember2020-01-012020-09-300000310158us-gaap:OperatingSegmentsMembercountry:USmrk:PharmaceuticalsegmentMember2019-01-012019-09-300000310158us-gaap:OperatingSegmentsMembermrk:PharmaceuticalsegmentMembermrk:InternationalMember2019-01-012019-09-300000310158us-gaap:OperatingSegmentsMembermrk:PharmaceuticalsegmentMember2019-01-012019-09-300000310158us-gaap:OperatingSegmentsMembercountry:USmrk:LivestockMembermrk:AnimalHealthsegmentMember2020-07-012020-09-300000310158us-gaap:OperatingSegmentsMembermrk:LivestockMembermrk:AnimalHealthsegmentMembermrk:InternationalMember2020-07-012020-09-300000310158us-gaap:OperatingSegmentsMembermrk:LivestockMembermrk:AnimalHealthsegmentMember2020-07-012020-09-300000310158us-gaap:OperatingSegmentsMembercountry:USmrk:LivestockMembermrk:AnimalHealthsegmentMember2019-07-012019-09-300000310158us-gaap:OperatingSegmentsMembermrk:LivestockMembermrk:AnimalHealthsegmentMembermrk:InternationalMember2019-07-012019-09-300000310158us-gaap:OperatingSegmentsMembermrk:LivestockMembermrk:AnimalHealthsegmentMember2019-07-012019-09-300000310158us-gaap:OperatingSegmentsMembercountry:USmrk:LivestockMembermrk:AnimalHealthsegmentMember2020-01-012020-09-300000310158us-gaap:OperatingSegmentsMembermrk:LivestockMembermrk:AnimalHealthsegmentMembermrk:InternationalMember2020-01-012020-09-300000310158us-gaap:OperatingSegmentsMembermrk:LivestockMembermrk:AnimalHealthsegmentMember2020-01-012020-09-300000310158us-gaap:OperatingSegmentsMembercountry:USmrk:LivestockMembermrk:AnimalHealthsegmentMember2019-01-012019-09-300000310158us-gaap:OperatingSegmentsMembermrk:LivestockMembermrk:AnimalHealthsegmentMembermrk:InternationalMember2019-01-012019-09-300000310158us-gaap:OperatingSegmentsMembermrk:LivestockMembermrk:AnimalHealthsegmentMember2019-01-012019-09-300000310158us-gaap:OperatingSegmentsMembercountry:USmrk:AnimalHealthsegmentMembermrk:CompanionAnimalsMember2020-07-012020-09-300000310158us-gaap:OperatingSegmentsMembermrk:AnimalHealthsegmentMembermrk:InternationalMembermrk:CompanionAnimalsMember2020-07-012020-09-300000310158us-gaap:OperatingSegmentsMembermrk:AnimalHealthsegmentMembermrk:CompanionAnimalsMember2020-07-012020-09-300000310158us-gaap:OperatingSegmentsMembercountry:USmrk:AnimalHealthsegmentMembermrk:CompanionAnimalsMember2019-07-012019-09-300000310158us-gaap:OperatingSegmentsMembermrk:AnimalHealthsegmentMembermrk:InternationalMembermrk:CompanionAnimalsMember2019-07-012019-09-300000310158us-gaap:OperatingSegmentsMembermrk:AnimalHealthsegmentMembermrk:CompanionAnimalsMember2019-07-012019-09-300000310158us-gaap:OperatingSegmentsMembercountry:USmrk:AnimalHealthsegmentMembermrk:CompanionAnimalsMember2020-01-012020-09-300000310158us-gaap:OperatingSegmentsMembermrk:AnimalHealthsegmentMembermrk:InternationalMembermrk:CompanionAnimalsMember2020-01-012020-09-300000310158us-gaap:OperatingSegmentsMembermrk:AnimalHealthsegmentMembermrk:CompanionAnimalsMember2020-01-012020-09-300000310158us-gaap:OperatingSegmentsMembercountry:USmrk:AnimalHealthsegmentMembermrk:CompanionAnimalsMember2019-01-012019-09-300000310158us-gaap:OperatingSegmentsMembermrk:AnimalHealthsegmentMembermrk:InternationalMembermrk:CompanionAnimalsMember2019-01-012019-09-300000310158us-gaap:OperatingSegmentsMembermrk:AnimalHealthsegmentMembermrk:CompanionAnimalsMember2019-01-012019-09-300000310158us-gaap:OperatingSegmentsMembercountry:USmrk:AnimalHealthsegmentMember2020-07-012020-09-300000310158us-gaap:OperatingSegmentsMembermrk:AnimalHealthsegmentMembermrk:InternationalMember2020-07-012020-09-300000310158us-gaap:OperatingSegmentsMembermrk:AnimalHealthsegmentMember2020-07-012020-09-300000310158us-gaap:OperatingSegmentsMembercountry:USmrk:AnimalHealthsegmentMember2019-07-012019-09-300000310158us-gaap:OperatingSegmentsMembermrk:AnimalHealthsegmentMembermrk:InternationalMember2019-07-012019-09-300000310158us-gaap:OperatingSegmentsMembermrk:AnimalHealthsegmentMember2019-07-012019-09-300000310158us-gaap:OperatingSegmentsMembercountry:USmrk:AnimalHealthsegmentMember2020-01-012020-09-300000310158us-gaap:OperatingSegmentsMembermrk:AnimalHealthsegmentMembermrk:InternationalMember2020-01-012020-09-300000310158us-gaap:OperatingSegmentsMembermrk:AnimalHealthsegmentMember2020-01-012020-09-300000310158us-gaap:OperatingSegmentsMembercountry:USmrk:AnimalHealthsegmentMember2019-01-012019-09-300000310158us-gaap:OperatingSegmentsMembermrk:AnimalHealthsegmentMembermrk:InternationalMember2019-01-012019-09-300000310158us-gaap:OperatingSegmentsMembermrk:AnimalHealthsegmentMember2019-01-012019-09-300000310158us-gaap:OperatingSegmentsMemberus-gaap:AllOtherSegmentsMembercountry:US2020-07-012020-09-300000310158us-gaap:OperatingSegmentsMemberus-gaap:AllOtherSegmentsMembermrk:InternationalMember2020-07-012020-09-300000310158us-gaap:OperatingSegmentsMemberus-gaap:AllOtherSegmentsMember2020-07-012020-09-300000310158us-gaap:OperatingSegmentsMemberus-gaap:AllOtherSegmentsMembercountry:US2019-07-012019-09-300000310158us-gaap:OperatingSegmentsMemberus-gaap:AllOtherSegmentsMembermrk:InternationalMember2019-07-012019-09-300000310158us-gaap:OperatingSegmentsMemberus-gaap:AllOtherSegmentsMember2019-07-012019-09-300000310158us-gaap:OperatingSegmentsMemberus-gaap:AllOtherSegmentsMembercountry:US2020-01-012020-09-300000310158us-gaap:OperatingSegmentsMemberus-gaap:AllOtherSegmentsMembermrk:InternationalMember2020-01-012020-09-300000310158us-gaap:OperatingSegmentsMemberus-gaap:AllOtherSegmentsMember2020-01-012020-09-300000310158us-gaap:OperatingSegmentsMemberus-gaap:AllOtherSegmentsMembercountry:US2019-01-012019-09-300000310158us-gaap:OperatingSegmentsMemberus-gaap:AllOtherSegmentsMembermrk:InternationalMember2019-01-012019-09-300000310158us-gaap:OperatingSegmentsMemberus-gaap:AllOtherSegmentsMember2019-01-012019-09-300000310158us-gaap:OperatingSegmentsMembercountry:US2020-07-012020-09-300000310158us-gaap:OperatingSegmentsMembermrk:InternationalMember2020-07-012020-09-300000310158us-gaap:OperatingSegmentsMember2020-07-012020-09-300000310158us-gaap:OperatingSegmentsMembercountry:US2019-07-012019-09-300000310158us-gaap:OperatingSegmentsMembermrk:InternationalMember2019-07-012019-09-300000310158us-gaap:OperatingSegmentsMember2019-07-012019-09-300000310158us-gaap:OperatingSegmentsMembercountry:US2020-01-012020-09-300000310158us-gaap:OperatingSegmentsMembermrk:InternationalMember2020-01-012020-09-300000310158us-gaap:OperatingSegmentsMember2020-01-012020-09-300000310158us-gaap:OperatingSegmentsMembercountry:US2019-01-012019-09-300000310158us-gaap:OperatingSegmentsMembermrk:InternationalMember2019-01-012019-09-300000310158us-gaap:OperatingSegmentsMember2019-01-012019-09-300000310158country:USus-gaap:CorporateNonSegmentMember2020-07-012020-09-300000310158us-gaap:CorporateNonSegmentMembermrk:InternationalMember2020-07-012020-09-300000310158us-gaap:CorporateNonSegmentMember2020-07-012020-09-300000310158country:USus-gaap:CorporateNonSegmentMember2019-07-012019-09-300000310158us-gaap:CorporateNonSegmentMembermrk:InternationalMember2019-07-012019-09-300000310158us-gaap:CorporateNonSegmentMember2019-07-012019-09-300000310158country:USus-gaap:CorporateNonSegmentMember2020-01-012020-09-300000310158us-gaap:CorporateNonSegmentMembermrk:InternationalMember2020-01-012020-09-300000310158us-gaap:CorporateNonSegmentMember2020-01-012020-09-300000310158country:USus-gaap:CorporateNonSegmentMember2019-01-012019-09-300000310158us-gaap:CorporateNonSegmentMembermrk:InternationalMember2019-01-012019-09-300000310158us-gaap:CorporateNonSegmentMember2019-01-012019-09-300000310158country:US2020-07-012020-09-300000310158mrk:InternationalMember2020-07-012020-09-300000310158country:US2019-07-012019-09-300000310158mrk:InternationalMember2019-07-012019-09-300000310158country:US2020-01-012020-09-300000310158mrk:InternationalMember2020-01-012020-09-300000310158country:US2019-01-012019-09-300000310158mrk:InternationalMember2019-01-012019-09-300000310158us-gaap:EMEAMember2020-07-012020-09-300000310158us-gaap:EMEAMember2019-07-012019-09-300000310158us-gaap:EMEAMember2020-01-012020-09-300000310158us-gaap:EMEAMember2019-01-012019-09-300000310158country:CN2020-07-012020-09-300000310158country:CN2019-07-012019-09-300000310158country:CN2020-01-012020-09-300000310158country:CN2019-01-012019-09-300000310158country:JP2020-07-012020-09-300000310158country:JP2019-07-012019-09-300000310158country:JP2020-01-012020-09-300000310158country:JP2019-01-012019-09-300000310158srt:AsiaPacificMember2020-07-012020-09-300000310158srt:AsiaPacificMember2019-07-012019-09-300000310158srt:AsiaPacificMember2020-01-012020-09-300000310158srt:AsiaPacificMember2019-01-012019-09-300000310158srt:LatinAmericaMember2020-07-012020-09-300000310158srt:LatinAmericaMember2019-07-012019-09-300000310158srt:LatinAmericaMember2020-01-012020-09-300000310158srt:LatinAmericaMember2019-01-012019-09-300000310158mrk:OtherCountriesMember2020-07-012020-09-300000310158mrk:OtherCountriesMember2019-07-012019-09-300000310158mrk:OtherCountriesMember2020-01-012020-09-300000310158mrk:OtherCountriesMember2019-01-012019-09-300000310158us-gaap:MaterialReconcilingItemsMember2020-07-012020-09-300000310158us-gaap:MaterialReconcilingItemsMember2019-07-012019-09-300000310158us-gaap:MaterialReconcilingItemsMember2020-01-012020-09-300000310158us-gaap:MaterialReconcilingItemsMember2019-01-012019-09-30


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
 
(Mark One)
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended September 30, 2020
OR
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from ______ to ______
Commission File No. 1-6571
Merck & Co., Inc.
(Exact name of registrant as specified in its charter)
New Jersey22-1918501
(State or other jurisdiction of incorporation)
(I.R.S Employer Identification No.)
2000 Galloping Hill Road
KenilworthNew Jersey07033
(Address of principal executive offices) (zip code)
(Registrant’s telephone number, including area code) (908) 740-4000
Not Applicable
(Former name, former address and former fiscal year, if changed since last report.)
Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  Yes     No  
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).  Yes     No  
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act. (Check one):
Large accelerated filerAccelerated filer
Non-accelerated filerSmaller reporting company
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).  Yes   No 
Securities Registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered
Common Stock ($0.50 par value)MRKNew York Stock Exchange
1.125% Notes due 2021MRK/21New York Stock Exchange
0.500% Notes due 2024MRK 24New York Stock Exchange
1.875% Notes due 2026MRK/26New York Stock Exchange
2.500% Notes due 2034MRK/34New York Stock Exchange
1.375% Notes due 2036MRK 36ANew York Stock Exchange
The number of shares of common stock outstanding as of the close of business on October 31, 2020: 2,530,034,437





Table of Contents
Page No.
PART I
Item 1.
Item 2.
Item 4.
PART II
Item 1.
Item 1A.
Item 2.
Item 6.





Part I - Financial Information
Item 1. Financial Statements
MERCK & CO., INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENT OF INCOME
(Unaudited, $ in millions except per share amounts)
 
 Three Months Ended
September 30,
Nine Months Ended
September 30,
 2020201920202019
Sales$12,551 $12,397 $35,479 $34,972 
Costs, Expenses and Other
Cost of sales3,481 3,990 9,952 10,443 
Selling, general and administrative2,450 2,589 7,383 7,726 
Research and development3,390 3,204 7,721 7,324 
Restructuring costs114 232 269 444 
Other (income) expense, net(312)35 (630)362 
 9,123 10,050 24,695 26,299 
Income Before Taxes3,428 2,347 10,784 8,673 
Taxes on Income483 440 1,611 1,259 
Net Income2,945 1,907 9,173 7,414 
Less: Net Income (Loss) Attributable to Noncontrolling Interests4 6 12 (73)
Net Income Attributable to Merck & Co., Inc.$2,941 $1,901 $9,161 $7,487 
Basic Earnings per Common Share Attributable to Merck & Co., Inc. Common Shareholders
$1.16 $0.74 $3.62 $2.91 
Earnings per Common Share Assuming Dilution Attributable to Merck & Co., Inc. Common Shareholders
$1.16 $0.74 $3.61 $2.89 
 
MERCK & CO., INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME
(Unaudited, $ in millions)
 
 Three Months Ended
September 30,
Nine Months Ended
September 30,
 2020201920202019
Net Income Attributable to Merck & Co., Inc.$2,941 $1,901 $9,161 $7,487 
Other Comprehensive Income (Loss) Net of Taxes:
Net unrealized (loss) gain on derivatives, net of reclassifications(137)91 (153)(9)
Net unrealized (loss) gain on investments, net of reclassifications (17)(18)109 
Benefit plan net gain and prior service credit, net of amortization
62 15 161 41 
Cumulative translation adjustment
85 (117)(180)14 
 10 (28)(190)155 
Comprehensive Income Attributable to Merck & Co., Inc.$2,951 $1,873 $8,971 $7,642 
 The accompanying notes are an integral part of these condensed consolidated financial statements.
- 3 -



MERCK & CO., INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE SHEET
(Unaudited, $ in millions except per share amounts)
 
September 30, 2020December 31, 2019
Assets
Current Assets
Cash and cash equivalents
$7,356 $9,676 
Short-term investments
 774 
Accounts receivable (net of allowance for doubtful accounts of $89 in 2020
 and $86 in 2019)
8,422 6,778 
Inventories (excludes inventories of $2,081 in 2020 and $1,480 in 2019
classified in Other assets - see Note 6)
6,128 5,978 
Other current assets
4,671 4,277 
Total current assets26,577 27,483 
Investments1,372 1,469 
Property, Plant and Equipment, at cost, net of accumulated depreciation of $18,572
in 2020 and $17,686 in 2019
16,919 15,053 
Goodwill20,248 19,425 
Other Intangibles, Net16,677 14,196 
Other Assets8,007 6,771 
 $89,800 $84,397 
Liabilities and Equity
Current Liabilities
Loans payable and current portion of long-term debt
$2,420 $3,610 
Trade accounts payable
3,744 3,738 
Accrued and other current liabilities
11,690 12,549 
Income taxes payable
984 736 
Dividends payable
1,567 1,587 
Total current liabilities20,405 22,220 
Long-Term Debt26,321 22,736 
Deferred Income Taxes1,777 1,470 
Other Noncurrent Liabilities12,027 11,970 
Merck & Co., Inc. Stockholders’ Equity
Common stock, $0.50 par value
Authorized - 6,500,000,000 shares
Issued - 3,577,103,522 shares in 2020 and 2019
1,788 1,788 
Other paid-in capital
39,489 39,660 
Retained earnings
51,107 46,602 
Accumulated other comprehensive loss
(6,383)(6,193)
86,001 81,857 
Less treasury stock, at cost:
1,047,343,390 shares in 2020 and 1,038,087,496 shares in 2019
56,815 55,950 
Total Merck & Co., Inc. stockholders’ equity29,186 25,907 
Noncontrolling Interests84 94 
Total equity29,270 26,001 
 $89,800 $84,397 
The accompanying notes are an integral part of this condensed consolidated financial statement.
- 4 -



MERCK & CO., INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS
(Unaudited, $ in millions)
 
 Nine Months Ended
September 30,
 20202019
Cash Flows from Operating Activities
Net income$9,173 $7,414 
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization
2,721 2,716 
Intangible asset impairment charges
35 864 
Charge for acquisition of Peloton Therapeutics, Inc. 982 
Deferred income taxes
47 (386)
Share-based compensation
354 306 
Other
(445)219 
Net changes in assets and liabilities
(5,638)(3,469)
Net Cash Provided by Operating Activities6,247 8,646 
Cash Flows from Investing Activities
Capital expenditures(3,170)(2,336)
Purchases of securities and other investments(78)(2,380)
Proceeds from sales of securities and other investments1,894 7,459 
Acquisition of ArQule, Inc., net of cash acquired(2,545) 
Acquisition of Antelliq Corporation, net of cash acquired (3,620)
Acquisition of Peloton Therapeutics, Inc., net of cash acquired (1,040)
Other acquisitions, net of cash acquired(907)(269)
Other141 320 
Net Cash Used in Investing Activities(4,665)(1,866)
Cash Flows from Financing Activities
Net change in short-term borrowings(311)(3,892)
Payments on debt(1,954) 
Proceeds from issuance of debt4,419 4,958 
Purchases of treasury stock(1,281)(3,730)
Dividends paid to stockholders(4,673)(4,290)
Proceeds from exercise of stock options68 344 
Other(